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ABSTRACT 
 Patients with life-limiting cancer and their families face unique challenges that interfere 
with their ability to make decisions or adequately express their health care preferences about end 
of life (EOL) treatment. As a result, patients at EOL often receive aggressive unwanted treatment 
that nationally costs billions of dollars and results in surrogate distress about not honoring patient 
wishes. Respecting Choices® DS-ACP is a disease-specific Advance Care Planning (ACP) 
intervention that is designed to overcome barriers associated with ACP and potentially decrease 
the incidence of unwanted, overly aggressive treatments at EOL. The intervention is delivered to 
patient-surrogate dyads by a trained facilitator who provides an opportunity for patients to 
identify values and goals that support their EOL choices and communicate these values and goals 
to their surrogates before they are in a medical crisis. Although Respecting Choices® DS-ACP 
has been effective with other populations, it has not been evaluated for patients with life-limiting 
cancer. Thus, the purpose of this study was to evaluate the Respecting Choices® DS-ACP 
intervention with patients with life-limiting cancer to determine if the intervention increases 
patient-surrogate congruence about the patient’s EOL wishes and reduces decisional conflict 
without causing anxiety. 
Study design was a Phase I clinical trial. A volunteer sample of 15 patients with a 
diagnosis of life limiting cancer and their matched surrogates participated in the study. The 
Statement of Treatment Preferences for Life-Limiting Cancer Form, the Spielberger State-
anxiety Scale Form Y-1 (STAI) and the Decisional Conflict Scale (DCS) were administered pre- 
and post-intervention. The Quality of Communication about End of Life Care Form was 
administered at post test. Descriptive statistics were used to describe the sample. McNemar Chi-
square and Binomial tests were conducted to investigate whether the intervention increased 
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congruence for five different situations on the Statement of Treatment Preferences for Life-
Limiting Cancer Form. The Zar’s Multiple Comparison Test of Differences was conducted to 
investigate the proportion of congruence observed across the five situations.  A paired-sample t 
test was conducted to evaluate post-intervention changes in anxiety (STAI) and decisional 
conflict (DCS). Frequencies and percentages were conducted for the five items on the Quality of 
Communication about End of Life Care Form to evaluate patients’ and surrogates’ satisfaction 
with the intervention.  Anecdotal comments about timing were content analyzed and 
summarized.  
Congruence between patients and surrogates improved significantly in all five situations 
(range of p =.001 to .031), decisional conflict lessened significantly (t (14) =4.49, p < .001), and 
anxiety did not change (t (14) = 1.75, p = .102) pre- and post-intervention. Participants reported 
satisfaction with the intervention, including its delivery and timing.  
Findings from this study provide guidance on how to assist patients with life limiting 
cancer and their surrogates with EOL decision making. Study findings also support making the 
Respecting Choices ACP intervention part of usual care for patients with life limiting cancer and 
timing the intervention so that it is delivered before a medical crisis occurs. The lack of change 
in post-intervention anxiety scores suggests that ACP does not add to patient distress when ACP 
is conducted by a trained facilitator. This finding can be used to persuade health professionals to 
refer their patients for ACP. Additional research is needed to determine if increased patient-
surrogate congruence leads to patients’ wishes being followed and reduces surrogate decisional 
conflict and distress at EOL. Future research is also needed to determine if the Respecting 
Choices DS-ACP intervention is equally effective with racial and ethnic groups whose reluctance 
v 
to engage in EOL discussion has been documented in the literature or if the intervention needs to 
be culturally adapted.  
  
vi 
ACKNOWLEDGMENTS 
I would like to express my deep appreciation and gratitude to my advisor, Dr Karen 
Aroian for her patient guidance, from helping me clarify my dissertation topic, through to 
completion of this degree. Her wisdom, knowledge and commitment to the highest standards has 
made this a thoughtful and rewarding journey.  
I extend my sincere gratitude and would like to acknowledge the support and direction of 
my dissertation committee members over the past three years as I moved from an idea to a 
completed study:  Dr. Anne Norris for her invaluable statistical support, advice and 
encouragement; Dr Julia Buckey for helping make sense of the confusion during my candidacy 
exam, offering valuable insights, and encouraging words when I needed them most; Dr. Susan 
Chase for her thought provoking suggestions; and Dr. Victoria Loerzel for her advice as I 
navigated the complexities of recruitment. 
To my husband and daughter, Gerry and Kimberly, who endured this long process with 
me, always offering support and love. To my parents Bill and Lucille Sharp, who have been 
constant sources of love, concern, support and spiritual strength.  
I also extend my sincere appreciation to Linda Briggs, Associate Director of Respecting 
Choices and Ethics Consultant, and Rana Limbo, Directive of Bereavement and Advance Care 
Planning of Gundersen Lutheran Medical Foundation, for the opportunity to collaborate with 
their organization for my dissertation research and for providing me significant support. I thank 
Linda Briggs for sharing her expertise, and for the opportunity extended to help me contribute to 
existing Advance Care Planning knowledge in a meaningful way. 
  
vii 
 
 
 
 
 
 
 
I dedicate my dissertation to my dear friend and colleague Melanie Culligan Schroeder, MSN, 
RN and to ALL the angels who guide, support, and comfort me daily. Our journey continues. 
There is still much work to be done. 
 
 
  
viii 
TABLE OF CONTENTS 
LIST OF TABLES ........................................................................................................................ xii 
CHAPTER 1: OVERVIEW ............................................................................................................ 1 
Introduction ............................................................................................................................... 1 
Background of Problem ............................................................................................................ 2 
Statement of Problem ................................................................................................................ 3 
Purpose of Study ....................................................................................................................... 4 
Research Questions ................................................................................................................... 4 
Hypotheses ................................................................................................................................ 5 
Definition of Terms................................................................................................................... 5 
Assumptions .............................................................................................................................. 7 
Significance............................................................................................................................... 8 
Outline of Remainder of Dissertation ....................................................................................... 8 
CHAPTER 2: REVIEW OF RELEVANT LITERATURE AND THEORETICAL 
FRAMEWORK................................................................................................................. 10 
Overview ................................................................................................................................. 10 
Factors Considered Important at EOL .................................................................................... 10 
EOL Treatment Decisions and Cancer Patients ...................................................................... 11 
Advance Directives ........................................................................................................... 11 
Scope of Advance Care Planning ..................................................................................... 12 
Role of Health Care Surrogates ........................................................................................ 13 
Inconsistency between ADs and Care Received ............................................................... 13 
Barriers to Effective Advance Care Planning ......................................................................... 15 
ix 
Ineffective or Delayed Communication ............................................................................ 15 
Fear of Causing Distress ................................................................................................... 18 
Inability to Predict Treatment Choices ............................................................................. 19 
Surrogates’ Understanding of Preferences........................................................................ 20 
Timing ............................................................................................................................... 21 
Research To Improve Patient-Surrogate Dyadic Congruence ................................................ 22 
Efforts to Improve Patient-Surrogate Communication ........................................................... 26 
Educational Interventions ................................................................................................. 26 
Values History and Facilitated ACP ................................................................................. 28 
Respecting Choices® Disease Specific Advance Care Planning ..................................... 31 
Theoretical Framework ........................................................................................................... 33 
CHAPTER 3: METHODS ............................................................................................................ 36 
Research Design...................................................................................................................... 36 
Independent and Dependent Variables ................................................................................... 36 
Population, Sample, and Setting ............................................................................................. 36 
Sample Selection ............................................................................................................... 37 
Eligibility and Exclusion Criteria ............................................................................... 37 
Recruitment ................................................................................................................. 37 
Sample Size, Power, and Significance .............................................................................. 39 
Setting ............................................................................................................................... 40 
Ethical Considerations ...................................................................................................... 40 
Informed Consent.............................................................................................................. 41 
Intervention ............................................................................................................................. 42 
x 
Respecting Choices® DS-ACP Interview ........................................................................ 42 
Respecting Choices Facilitator Training ........................................................................... 43 
Instruments .............................................................................................................................. 45 
Sociodemographic Form ................................................................................................... 45 
Statement of Treatment Preferences for Life-limiting Cancer ......................................... 45 
Decisional Conflict Scale .................................................................................................. 46 
Spielberger State Anxiety Scale S-anxiety Scale .............................................................. 47 
Quality of Communication about End-of-life Care .......................................................... 49 
Data Collection Procedure ...................................................................................................... 50 
Data Analysis Plan .................................................................................................................. 52 
Research Question 1 ......................................................................................................... 52 
Research Question 2 ......................................................................................................... 53 
Research Questions 3 and 4 .............................................................................................. 53 
Analysis Assessing Fidelity and Timing of Intervention .................................................. 54 
CHAPTER 4: RESULTS .............................................................................................................. 55 
Descriptive Statistics ............................................................................................................... 55 
Sample............................................................................................................................... 55 
Research Question 1 ......................................................................................................... 58 
Research Question 2 ......................................................................................................... 59 
Research Question 3 ......................................................................................................... 60 
Research Question 4 ......................................................................................................... 61 
Additional Analyses Assessing Intervention Fidelity and Timing ......................................... 61 
Intervention Fidelity.......................................................................................................... 61 
xi 
Timing ............................................................................................................................... 62 
CHAPTER 5: DISCUSSION ........................................................................................................ 64 
Implications............................................................................................................................. 64 
Limitations .............................................................................................................................. 67 
Implication for Practice and Policy......................................................................................... 70 
Implications for Future Research ............................................................................................ 71 
APPENDIX A: STATEMENT FOR TREATMENT PREFERENCES FOR LIFE-LIMITING 
CANCER .......................................................................................................................... 73 
APPENDIX B: VERBAL ASSESSMENT QUESTIONS ........................................................... 76 
APPENDIX C: INTRODUCTORY LETTER.............................................................................. 78 
APPENDIX D: INFORMED CONSENT .................................................................................... 80 
APPENDIX E: RESPECTING CHOICES ® DS-ACP INTERVIEW STAGES ........................ 87 
APPENDIX F: SOCIODEMOGRAPHIC INSTRUMENTS ....................................................... 90 
APPENDIX G: DECISIONAL CONFLICT SCALE................................................................... 98 
APPENDIX H: SPIELBERGER STATE ANXIETY SCALES ................................................ 100 
APPENDIX I: QUALITY OF COMMUNICATION ABOUT END-OF-LIFE CARE ............. 103 
 
  
xii 
 
LIST OF TABLES 
Table 1. Data Collection Method by Time Pre-and Post- Intervention (Patients, Surrogate) ...... 52 
Table 2. Socio-Demographic Characteristics ............................................................................... 56 
Table 3. Results for McNemar and Binomial Tests for Congruence at Pretest and Posttest ........ 59 
Table 4. Zar’s Multiple Comparison Test of Differences in Proportions of Congruence across 
Situation at Post-test ......................................................................................................... 60 
Table 5. Results of Paired Sample t Test for DCS Scores by Time (Pretest vs. Posttest) ............ 60 
Table 6. Results of Paired Sample t Test for Anxiety/Stress Scores by Time (Pretest vs. Posttest)
........................................................................................................................................... 61 
Table 7. Frequencies and Percentages for Analyses Assessing Intervention Fidelity and Timing
........................................................................................................................................... 63 
  
1 
CHAPTER 1: OVERVIEW 
Introduction 
The study was a Phase I clinical trial to evaluate an intervention to assist patients with life 
limiting cancer to formulate and express their end-of-life preferences to family members and 
health care professionals. An estimated 1.5 million Americans receive a diagnosis of cancer 
annually and more than 1,500 patients die every day from the disease (American Cancer Society 
[ACS], 2010).  Patients with life-limiting cancer and their families face unique challenges that 
interfere with their ability to make decisions or adequately express their health care preferences 
about end of life (EOL).  Life-limiting cancer patients typically maintain good functioning for a 
long period and then experience a rapid decline as the illness becomes overwhelming and leads 
to death (Lorenz et al., 2008; Lynn, 2005;  Morita, Tei, & Inoug, 2003; Teno, Weitzen, Fennell 
& Mor, 2001).  During their decline, these patients often endure intense symptoms that cause 
them to lose decision-making capacity.  Very often, they have not communicated their 
preferences in advance to family members, leaving family members unprepared to make EOL 
decisions on their behalf. As a result, life-limiting cancer patients often receive care at the EOL 
that is inconsistent with their preferences (Goodman et al., 2010; McCarthy, Philips, Zhong, 
Drews & Lynn, 2000; Teno, Fisher, Hamel, Coppola, & Dawson, 2002).   
 Advance care planning (ACP) and advance directives (ADs) provide a general 
framework for decision making near the EOL by having patients identify their preferences for 
life-sustaining care ahead of time before they lose decision-making ability.  Instructional ADs 
contain directives regarding what treatments patients want and the conditions under which they 
want treatments withheld.  Proxy ADs enable patients to select surrogates, people they want to 
make decisions on their behalf if they are unable to do so.  ACP is the process of identifying 
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goals, values, and beliefs about healthcare decisions that may need to be made in the future to 
assist patients and surrogates to prepare or enact instructional ADs. 
Background of Problem 
The Patient Self-Determination Act (PSDA) (42 U.S.C. 1395cc (a), 1990) specifies the 
need for instructional or proxy ADs to improve EOL experiences by communicating patients’ 
wishes to family members and health professionals.  The national guidelines for applying the 
PSDA to cancer is for patients diagnosed with life-limiting cancer and life expectancy of 1 year 
or less to have completed ACP and ADs (National Comprehensive Cancer Network [NCCN], 
2010).     
Despite these guidelines and two decades of legislation and studies, AD completion rates 
remain low. According to various reports they are between 18%-30% (Covinsky et al., 2000; 
Kish, Martin, & Price, 2000; Lo & Steinbrook, 2004; Wilkerson, Wenger, & Shugarman, 2007).  
Various ACP interventions aimed at increasing the completion of effective ADs have been tried 
(Coppola, Ditto, Danks, & Smucker, 2001; Ditto et.al., 2001; The SUPPORT Principal 
Investigators, 1995), but most interventions have not been effective.  Even when ADs have been 
completed, they are often ineffective (Covinsky et al. 2000; Kish et al., 2000; Lo & Steinbrook, 
2004;Wilkerson et al., 2007) leading to default medical care which often ends up being different 
and more aggressive than what patients want (Goodman et al., 2010; Wennberg, Fisher, 
Goodman, & Skinner, 2008).  
There are a number of reasons for the lack of success with ACP and ADs.  In actual 
practice, health care providers typically fail to initiate meaningful advance care discussions, 
perhaps because they lack the skills or time to do so (Baile, Lenzi, Parker, Buckman, & Cohen, 
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2002; Curtis, Patrick, Caldwell & Collier, 2000; Fischer, Tulsky, Rose, Siminoff, & Arnold, 
1998; Tung, 2009; Yedidia, 2007). As a result, patient and surrogates often lack understanding of 
both the benefits and possible untoward consequences of EOL treatment options (Fried, Bradley, 
Towle, & Allore, 2002).  Surrogates also may not know patients’ values and decision choices 
because patients and surrogates avoid discussions of EOL in order to avoid upsetting one another 
(Briggs, 2003; Fried & O’Leary, 2008; Quill, 2000; Zhang & Siminoff, 2003).  Additional 
problems pertain to timing: If advance planning occurs too early, it may rely on hypothetical 
situations.  Patients cannot predict future decision choices for situations that they have not yet 
experienced (Fried et al., 2002; Fried, et al., 2007). On the other hand, if AD planning is delayed 
too long, ADs risk being formulated during stressful times when patients’ decision making 
capacity is already compromised (Covinsky et al., 2000).   
 Statement of Problem  
For patients with life-limiting cancer, planning for future health care decisions is more 
dynamic and complex than for patients with well managed illnesses. This dynamism and 
complexity poses additional ACP demands on professional facilitators, patients, and surrogates.   
Respecting Choices® DS-ACP is a disease-specific ACP intervention that is designed to 
overcome barriers associated with ACP and ADs.  The intervention is delivered by a trained 
health professional and includes both patients and surrogates.  The facilitator explores the 
patient’s understanding of his or her current illness, the likelihood of future complications, the 
benefits and burdens of treatment options, and the patient’s values and goals (Briggs & Hammes, 
2008/2010; Fried et al, 2006; Fried et al. 2002) and provides an opportunity for patients to 
communicate values and beliefs that support their EOL choices to their surrogates.   
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The Respecting Choices® intervention for patients and their surrogates has been 
successful in various populations, including patients with chronic illnesses (Briggs, 2003; Briggs, 
Kirchhoff, Hammes, Song, & Colvin, 2004; Detering, Hancock, Reade,& Silvester, 2010;  
Kirchhoff, Hammes, Kehl, Briggs, & Brown, 2010), patients undergoing cardiac surgery (Song, 
Kirchhoff, Douglas, Ward, & Hammes, 2005), geriatric patients (Schwartz et al., 2002), and 
adolescents living with HIV ( Lyon et al., 2009).  However, Respecting Choices® DS-ACP has 
not been evaluated for patients with life-limiting cancer.  
Purpose of Study 
The purpose of this study was to evaluate whether an ACP intervention using Respecting 
Choices® DS-ACP, delivered early in the cancer care continuum, increases patients and 
surrogates congruence and reduces patients’ decisional conflict without causing anxiety. The 
general guidelines for Respecting Choices ACP were adapted in this study to be disease- specific 
for patients with life-limiting cancer.   
Research Questions 
The study answered the following research questions: 
RQ1: Does the intervention increase congruence between patients and matched 
surrogates about patients’ treatment preferences for life-limiting cancer?   
RQ2: Are there significant differences in the proportion of congruence observed for 
different situations post-intervention?   
RQ3: Does the intervention reduce patients’ decisional conflict?   
RQ4: Does the intervention increase patients’ anxiety?   
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Hypotheses 
Based on the proposed research questions, the following hypotheses were developed: 
HA1: The intervention will increase congruence of treatment preferences for life-    
limiting cancer questionnaire (pretest versus posttest) between patients and matched surrogates. 
HA2: There will be significant differences in the proportion of congruence observed for 
different situations post intervention. 
HA3: The intervention will reduce patients’ decisional conflict. 
HA4: The intervention will not increase patients’ anxiety. 
Definition of Terms 
The terms utilized throughout this proposal are defined as follows. 
Advance care planning (ACP). A process of communication to assist individuals in 
understanding, reflecting upon, and discussing their goals, values, and beliefs about future health 
care decisions in the hypothetical event that individuals are no longer able to speak for 
themselves (Briggs & Hammes, 2008).  ACP often culminates in the creation of an advance 
directive.   
Advance care planning facilitator (ACP facilitator). A designated individual who has 
successfully completed an advance care planning facilitator skills training program to lead 
advance care planning discussions and related activities (Briggs & Hammes, 2008/2010).   
Advance directives (ADs). A general term that describes two kinds of legal documents: 
living wills and medical power of attorney.  These documents allow a person to give instructions 
about future medical care should he or she be unable to participate in medical decisions due to 
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serious illness or incapacity.  Each state regulates the use and application of advanced directives 
differently (National Hospice and Palliative Care Organization [NHPCO], n.d.).   
Decisional conflict. Uncertainty about which course of action to take when the choice 
among competing actions involves risks, loss, regret, or challenges personal life values (NHPCO, 
n.d.).    
End of life (EOL). A variable time prior to death when an individual experiences 
disability or worsening of a disease process (Briggs & Hammes, 2008/2010).  
Health care provider. Any licensed professional who is responsible for delivering health 
care services, including physicians, nurses, nurse practitioners, social workers, pharmacists, 
respiratory therapists, and so on (Briggs & Hammes, 2008/2010). 
Health care surrogate (surrogate). The person named in an advance directive or 
permitted under state law to make health care decisions on behalf of the person who is no longer 
able to make medical decisions (NHPCO, n.d.).   “Any competent adult expressly designated by 
a principle to make healthcare decisions on behalf of the principle upon the principles 
incapacity” (Florida Statutes, 2009).    
Life-limiting cancer. An initial or recurrent diagnosis of advanced cancer or invasive 
cancer. Advanced cancer is cancer that has grown beyond the organ in which it first started or 
affects a vital organ that cannot be removed. Invasive cancer is when cancer cells have 
penetrated the original layer of tissue (ACS, 2010).        
Life-sustaining treatment. Any intervention that prolongs life, including technical and 
invasive treatment (e.g., ventilators, dialysis) or less aggressive treatments (e.g., antibiotics, IV 
fluids, and tube feedings; Briggs & Hammes, 2008).   
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 Principle of nonabandonment.  Reflects the healthcare providers’ longitudinal 
commitment to care about patients and jointly seek solutions to problems with patients 
throughout their illness. This open-ended commitment to face the future together becomes more 
important as the future becomes less certain (Quill & Cassel, 1995).    
Substituted judgment. The form of surrogate decision making regarding EOL care in 
which the surrogate attempts to establish with as much accuracy as possible what decision the 
patient would have made if the patient was competent to do so.  This conclusion can be based on 
the patient’s preference expressed in previous statements or the surrogate’s knowledge of the 
patient’s beliefs, values, personality, and prior lifestyle.  This standard seeks to preserve the 
patient’s right of self-determination by placing the patient’s own preferences at the center of 
deliberation (Ascension Health Care Ethics, n.d.: Fl. Statutes, 2009). 
Assumptions 
The research was based on the following assumptions: 
Patients with life-limiting cancer have pre-existing knowledge and ideas (representations) 
about their health problems.  
Effective patient education is most likely to occur when patients’ knowledge and beliefs 
(representations) are elicited before new information is provided.  
Assessing patients’ representation about a health problem provides a context in which 
ACP facilitators can give specific, highly relevant, individualized information that will have a 
greater chance of being accepted by the patient (Donovan & Ward, 2001).    
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Significance 
Findings from this study provide information about how to assist patients with life 
limiting cancer and their surrogates with EOL decision making. Information about an 
intervention that clarifies patient wishes and increases surrogate understanding of those wishes 
has the potential to not only impact patient suffering from side effects of aggressive unwanted 
treatment and surrogate distress about honoring patient wishes at EOL but also reduce the 
billions of dollars of unwanted treatment currently spent at EOL for patients with life-limiting 
cancer (Smith & Hillner, 2011; Zhang et al., 2009).  Findings from this study also answer 
questions about when in the patients’ cancer trajectory is it appropriate to discuss EOL with 
patients with life limiting cancer and whether these discussions increase patient anxiety. 
Answering the latter question addresses provider concerns about possible negative effects of 
EOL discussions, thereby removing one barrier to EOL planning.   
Outline of Remainder of Dissertation  
Chapter 1 has served to provide an overview of why effective interventions are needed to 
improve patient-surrogate dyadic congruence and reduce patients’ decisional conflict without 
causing anxiety. Chapter 2 is a review of the literature and discussion of the theoretical 
framework that organizes this research project.  The specific focus is literature about barriers to 
completing ADs and studies that address strategies to improve EOL care so that is consistent 
with patients’ preferences.  These studies include a critical review of the Respecting Choices® 
DS-ACP intervention and how it has been implemented and evaluated to date.  Chapter 2 also 
introduces the theory of the representational approach to patient education, which is the 
theoretical basis to the Respecting Choices intervention.  The Respecting Choices DS-ACP 
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intervention, the study design and research procedures are described in Chapter 3.  Chapter 4 
reports the study findings. Chapter 5 discusses research questions and hypotheses supported or 
refuted by the findings 
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CHAPTER 2: REVIEW OF RELEVANT LITERATURE AND THEORETICAL 
FRAMEWORK 
Overview 
 A review of the literature and theoretical framework for the research is presented in this 
chapter.  The review of literature focuses on barriers to effective ACP, patient-surrogate dyadic 
congruence, and literature specific to patients with advanced cancer and ACP/EOL discussions.  
The Respecting Choices® DS-ACP intervention, the intervention evaluated in this study, is 
evaluated in terms of its implementations to date.  The theory of representational approach to 
patient education, which served as the theoretical basis to the Respecting Choices DS-ACP 
intervention, is introduced.  
Factors Considered Important at EOL 
 The literature about EOL has a number of foci, including factors considered most 
important to those people who are eminently approaching EOL, the people who care for them, 
and healthcare providers (Emanuel, Alpert, Baldwin, & Emanuel, 2000; Singer, Martin, & 
Kelner, 1999; Steinhauser et al., 2000).  The overarching conclusions from all these studies are 
that support for decision making about EOL is essential and that this support must include 
explicit communication about the difficult decisions patients and their surrogates are likely to 
face and detailed information about patients’ wishes. This support and communication is to help 
patients achieve a sense of control, thereby relieving burden on surrogates and strengthening 
relationships between patients and surrogates. Although these studies were about EOL in 
general, the same support requirements likely apply to ACP and EOL care for patients with life-
limiting cancer.   
11 
EOL Treatment Decisions and Cancer Patients 
Advance Directives 
 Written ADs in the form of living wills and appointments of health care surrogates allow 
patients to communicate their wishes before they reach decisional incapacity. These documents 
are intended to help patients with life-limiting illnesses avoid aggressive and futile life-sustaining 
treatments.  
Hospice and patient rights advocates identified the need for written ADs in the 1990s.  
Since 1991, the federal Patient Self-Determination Act ([PSDA] 1990) requires Medicare and 
Medicaid providers to inform all adult patients of their rights to prepare an AD, participate in and 
direct their own health care decisions, accept or refuse treatment, and be informed of the health 
care facility’s policy on the administration and application of these rights. 
 Despite widespread support for the concept of ADs, the potential benefits of written ADs 
have not been actualized.  According to Fagerlin and Schneider (2004), a number of conditions 
must be satisfied for written ADs to function as intended.  The first condition involves patients 
completing an AD. Second, those individuals charged with making decisions for the patient (i.e., 
surrogates) must understand and be willing to follow the instructions written in the ADs.  
These two seemingly facile tasks are more complicated than they appear to be.  People 
must decide in the present what treatment they would want in the future should they become 
incompetent.  The ADs must accurately state patients’ preferences in terms that are 
understandable by medical teams and surrogates.  Completed ADs must be made available to 
individuals charged with making decisions for the patient.  Concerns about the achievability of 
these conditions have been echoed by many experts in EOL decision making (see, for example, 
Ditto et al., 2001; Fagerlin & Schneider, 2004; Lo & Steinbrook, 2004; Perkins, 2007; Seckler, 
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Meier, Mulvihill, & Paris, 1991; Teno, Lynn & Phillips, 1994; Teno et al., 1997; Teno, Nelson, 
& Lynn, 1994).  These concerns may account for why AD completion rates have remained low.  
For example, a study that evaluated the frequency of use of ADs by critically ill cancer patients 
at a tertiary cancer center found that this population of patients only had a 27% completion rate 
(Kish et al., 2000).  
Scope of Advance Care Planning 
 Completing an AD is part of a broader process of advance care planning (ACP).  ACP 
requires patients, surrogates, and providers to come together to develop a plan that meets the 
patients’ goals, values, and preferences.  Engaging in ACP early in the cancer care continuum is 
especially important because delirium and other forms of cognitive impairment are prevalent 
during treatment of advanced malignancies (Lynn, 2005; McCarthy et al. 2000; Morita, et al., 
2003).    
 Early efforts to improve cancer care communication through ACP focused on ADs that 
primarily addressed resuscitation preferences.  More recent efforts reflect the opinion that ACP 
must be expanded beyond simple ADs.  Planning for EOL has evolved from the goal of having a 
patient complete ADs to engaging a patient in the process of thinking about what kind of life-
prolonging medical care he or she would want should the need arise.  Additional components 
include identifying a surrogate decision maker who will communicate the patient’s wishes if the 
patient is unable to do so and helping the patient to communicate his or her wishes to the 
surrogate (Levi, Dellasega, Whitehead, & Green, 2010).  In short, although ACP may lead to 
completion of ADs, its primary purpose is to facilitate the process of thinking about and 
communicating wishes so that more informed care can be delivered at EOL. 
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Role of Health Care Surrogates 
One aspect of ACP involves delegating surrogates to make decisions on one’s behalf in 
the event that one is no longer able to do so because of illness. Under the current U.S. model, 
surrogates are instructed to provide substituted judgment, choosing what the patient would have 
chosen  based on the surrogate’s knowledge of the patient’s goals and values, the patient’s prior 
behavior, or discussions with the patient about his or her preferences. If the patient never had the 
decisional capacity or the patients’ preferences are unknown, a decision should be made in the 
patients best interests (The President’s Council on Bioethics, 2005; Civil Rights Act, 2010). 
There is emerging consensus against relying solely on substituted judgment or best interests 
standards to judge the quality of a surrogate’s decisions (see for example, Fagerlin, Ditto, Danks,  
Houts,  & Smucker, 2001; Fagerlin & Schneider,2004; Fins et al., 2005; Shalowitz, Garrett-
Mayer, & Wendler, 2006;  Smucker et al., 2000; Sulmasy et al., 1998). In fact, many experts 
challenge the ability of surrogates to use substituted judgment to accurately represent the 
treatment preferences of patients (see for example, Fagerlin et al., 2001 Rosenfeld, Wenger, & 
Kagawa-Singer, 2000; Shalowitz, Garrett-Mayer, & Wendler, 2006).  
Inconsistency between ADs and Care Received 
 For patients with life-limiting cancer, the last six months of life are typically 
characterized by functional decline, severe pain and confusion that could have been controlled 
better by palliative care (Morita et al., 2003).  Although patients increasingly prefer comfort care 
as they near death, many die in pain (McCarthy et al., 2000) receiving aggressive cancer 
treatment at EOL instead of palliation. In other words, they die receiving care that may actually 
be unnecessary or harmful.  Findings from the landmark Study to Understand Prognoses and 
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Preferences for Outcomes and Risks of Treatments ([SUPPORT] The SUPPORT Principle 
Investigators, 1995) showed that, among patients with colon and lung cancer, 40% were in 
serious pain in the last days of life.  More than 65% of these patients who died in serious pain 
had stated a preference for comfort care (McCarthy et al., 2000).  Furthermore, one in 10 patients 
with lung and colon cancer received care that was incongruent with their preferences, as reported 
by family members (Lynn, Harrell, Cohn, Wagner, & Connors, 1997).    
 Aggressive treatment of cancer, even among patients with poor prognosis, continues to 
increase (Asola, Huhtala, & Holli, 2006; Earle et al., 2004; Goodman et al., 2010). The number 
of claims submitted to Medicare for patients with advanced cancer indicated the percentage of 
patients receiving chemotherapy within two weeks of death increased from 13.8% in 1993 to 
18.5 % in 1996, and there were similar increases in numbers of emergency room visits and 
intensive care unit stays (Earle et al., 2004).  It should not be assumed these statistics reflect a 
greater desire for aggressive care at EOL.  In a study involving 335 patients with breast cancer, 
at 2 months before death, 64% of patients continued to receive endocrine therapy and 20% 
received chemotherapy, despite deterioration in their general condition.  This situation is 
contrary to the medical standard of care, which specifies that at about two months prior to death, 
cancer-related treatment should be discontinued in favor of comfort measures (Asola et al., 
2006).  
 There is some evidence that continuing to receive aggressive treatment at EOL when the 
AD states preferences for comfort measures may be particularly common in patients with life-
limiting cancer.  In a study that prospectively compared resuscitation status for patients with 
advanced cancer and patients with amyotrophic lateral sclerosis (ALS; Astrow et al., 2008), 6 of 
the 24 patients with cancer with DNR orders were found to have received CPR, whereas none of 
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the six patients with ALS with DNR orders received CPR.  Because of the small numbers in the 
study, the differences between the two groups were not statistically significant.  Even so, these 
numbers demonstrate the failure to honor cancer patients’ EOL wishes. 
Barriers to Effective Advance Care Planning 
Ineffective or Delayed Communication 
 For patients with life-limiting cancer, relevant medical intervention options typically 
include short-term or terminal ventilator support, artificial nutrition and hydration, resuscitation, 
and hospice care (Martin, Emanuel, & Singer, 2000). Informed decisions about EOL care require 
a certain level of knowledge about these medical intervention options and their intended purpose.     
 Most cancer patients want to be informed if their illness is terminal and want information 
about treatment options tailored for their individual needs (Hagerty, Butow, Ellis, Dimitry, & 
Tattersall, 2005). Yet, ACP discussions may occur less frequently with this population than with 
patients who have other life-limiting illnesses. A retrospective examination of charts of elderly 
patients with advanced cancer found that only 38% had ACP discussions documented (Bradley 
et al., 2001).  A 2-year longitudinal study that involved reviewing medical records of 60 patients 
with advanced cancer and 32 patients with ALS found that the rate of ACP discussions differed 
in the two groups (Astrow et al., 2008). Although the patients with life-limiting cancer had 
significantly poorer survival prognoses than did the patients with ALS, medical records indicated 
that health care practitioners had far fewer ACP discussions with patients with life-limiting 
cancer than they had with patients with ALS.  Regardless of the reasons for this disparity, 
patients with life-limiting cancer appear to be less adequately prepared for EOL decision making 
(Astrow et al., 2008).   
16 
 The Astrow et al. (2008) study findings are consistent with a report that patients with life-
limiting cancer are not fully informed about palliative care as an alternative or supplement to 
curative care (Gattellari, Voigt, Butow, & Tattersall, 2002).  Similarly, a report on cancer care at 
EOL published by the Dartmouth Atlas Project (Goodman et al., 2010) found that one in three 
Medicare cancer patients spend their last days in hospitals and intensive care units. This finding 
suggests that many clinical teams administer aggressive treatment with curative attempts the 
patients may not want, negatively impacting their quality of their life in their last weeks and 
months (Goodman et al., 2010).  
 Responsibility for hesitancy to discuss EOL issues has been attributed to ambivalence of 
both the patient and the physician (Cherlin et al., 2005; Hagerty et al., 2005; Wright et al., 2008).  
Although there is evidence that patients with life-limiting cancer want their health care 
practitioners to initiate communications about ACP, providers rarely take the first step.  Instead, 
these health care professionals wait for their patients to raise the topic or initiate the conversation 
(Baile, et al., 2002; Bradley et al., 2001; Walling et al., 2008).  
 Patient ambivalence is also reflected in a study by Lamont and Siegler (2000). They 
found that patients with life-limiting cancer were willing to endorse a policy whereby medical 
house staff discuss advance care preferences as part of the admission history.  However, these 
same patients did not want to have ACP discussions with their oncologist. Perhaps patients are 
reluctant to initiate these discussions with their oncologists because of fears of being abandoned 
as their illness progresses (Back et al., 2008). Another study clarified that patients with cancer 
may be reluctant to discuss their advance care preferences with their oncologist but would do so 
if the discussion was initiated by their oncologist (Dow et al., 2010).  It is possible that although 
patients with life-limiting cancer want to be involved in decisions about the care they will 
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receive at EOL, they equate these discussions with being abandoned, particularly if they occur at 
a time when the future becomes less certain (Quill & Cassel, 1995).  Even if the evidence about 
patients’ wanting these discussions with their oncologists is inconclusive, it is clear that patients 
with life-limiting cancer want to know that they will receive quality care and support even if 
curative treatments are ineffective (Evans, Tulsky, Back, & Arnold, 2006).  
 When advance care discussions do take place, studies suggest that clinicians do an 
inadequate job communicating with patients and families. One area of inadequacy involves 
providing relevant information in an understandable format (Bradley et al., 2001; Christakis & 
Lamont, 2000).  For example, Fried, Bradley, and O’Leary (2003) examined agreement between 
patients or caregivers and providers regarding prognoses communication and found that, 
although providers reported having informed the patient and/or caregiver of a life-threatening 
condition, 46% of the patients and 34% of the caregivers reported no such discussion.  In 23% of 
patient/provider and 30% of caregiver/provider pairs, the provider reported discussing an 
approximate life expectancy, whereas the patient or caregiver reported no such discussion.  
 Curtis, Patrick, Caldwell, and Collier (2000) found that one of the most frequently 
identified barriers to communication about EOL care identified by 57 physicians and their 
patients with AIDS was too little time during medical appointments. Lack of time is also a 
barrier for oncologists. Baile et al. (2002) examined the attitudes and practices of 167 oncologists 
regarding discussions of unfavorable medical information with their patients; the oncologists 
reported lack of time as the most common barrier to communicating matters about EOL care.  
Other commonly noted barriers included providers’ limited formal training, feelings of 
unpreparedness, and the belief that conducting ACP discussions is complex (Tung, 2009; 
Yedidia, 2007).  Topics related to the need for training to engage in the complexities of ACP 
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include fear of causing distress, helping patients make decisions for future treatment when 
treatment options are unpredictable, helping surrogates understand patient choices, and timing 
for ACP. 
Fear of Causing Distress 
ACP discussions require patients to confront the limitations of medical treatments and the 
reality that life is finite, which can cause psychological distress (Quill, 2000).  Research suggests 
that both physicians and patients are ambivalent about talking about death and often avoid these 
conversations (Back et al., 2008; Baile et al., 2002; Bradley et al., 2001; Hancock et al., 2007; 
Kish et al., 2000).  This ambivalence also extends to patients and their surrogates. Patients’ and 
surrogates’ fears and concerns of emotional distress, not wanting to upset loved ones, and a 
belief in positive thinking may prevent these dyads from discussing EOL issues with each other 
(Zhang & Siminoff, 2003).  
On the other hand, a systematic review of 46 studies suggests that most of these reported 
fears are unfounded; patients and family members are capable of discussing EOL issues without 
experiencing undue anxiety (Hancock et al., 2007).  This conclusion is further substantiated by a 
multisite, prospective, longitudinal cohort study of patients with advanced cancer and their 
caregivers (Wright et al., 2008); 300 dyads were interviewed periodically from enrollment to the 
patient’s death, which occurred approximately four months after the first interview.  Within 2-3 
weeks of the patients’ death, medical records were reviewed and caregivers were interviewed to 
assess the patients’ quality of life near death. Bereaved caregivers’ psychiatric illnesses and 
quality of life were assessed approximately six months after the patients’ death.  There were no 
group differences in patients’ and caregivers’ mental health among people who did and did not 
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discuss EOL issues with providers. In other words, there was no evidence EOL discussions were 
significantly associated with increased emotional distress or psychiatric disorders. Instead, 
patients that did not have EOL discussion received significantly more aggressive medical care in 
their final week of life, which was associated with worse patient quality of life near death 
(Wright et al.).  
 Similar to the findings reported by Wright et al. (2008), receiving a patient-surrogate 
ACP intervention (i.e., discussing and planning for EOL) did not result in increased anxiety for 
members of the intervention group (Song et al., 2005). More specifically, there was no 
significant difference in anxiety scores pre- and post intervention in the treatment and control 
groups.  Findings from these studies suggest that talking about EOL is not associated with 
greater distress or anxiety (Hancock et al., 2007; Lyon et al., 2009; Song et al., 2005; Tang, Li, & 
Chen, 2008).  In fact, EOL discussions may result in increased patient understanding of illness 
severity, fewer invasive procedures, lower rates of ICU admissions, and earlier hospice referrals 
at EOL (Wright et al., 2008). In other words, avoiding EOL care planning may not be in the 
patients’ best interest. 
Inability to Predict Treatment Choices  
 Another potential barrier to ADs and traditional ACP includes patients’ inability to 
predict their future treatment preferences because of the difficulty anticipating all of the 
situations the patients may face (Fried et al., 2006; Fried & O’Leary, 2008; Teno et al., 1997; 
Winzelberg, Hanson, & Tulsky, 2005).  Patients or their surrogates may discover an AD created 
during a period of relative health may not be applicable during a subsequent period of illness or 
incapacity (Fried et al., 2006).  
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Patients and surrogates often lack or misunderstand information about medical and 
treatment options, and/or have inaccurate preconceptions about the nature of the decisions at 
hand.  For example, many people may be opposed to the notion of being placed on a ventilator, 
but whether patients may be willing to endure mechanical ventilation likely will depend on the 
reality of the circumstances (e.g., need for short- versus long-term mechanical ventilation, or 
overall prognosis for recovery).  Health care practitioners not only lack the time, but also the 
skill needed to conduct in-depth discussions of EOL treatment decisions that consider key 
circumstances or qualifying conditions (Cherlin et al., 2005; Tung, 2009; Yedidia, 2007).   
 Another reason for patients’ inability to predict future medical decisions is their over- or 
underestimation of the impact that specific disabilities will have on their lives (Fried et al., 
2006).  For example, patients may think they may be willing to accept losing the ability to walk 
or talk, but not the loss of cognition.  Their willingness may change once they actually begin to 
lose the ability to walk or talk.  In other words, patient preferences and the values underlying 
those preferences may change over time and with experience.  Caregivers, surrogates, and 
patients’ health care providers may be challenged to make decisions that run counter to patients’ 
original AD, unless ACP addressed the possibility that preferences might change as the illness 
progresses. 
Surrogates’ Understanding of Preferences 
 Although patients may believe their ADs clearly express their preferences, these 
preferences may be less clear to surrogates.  First, patients’ expressed preferences for EOL often 
do not apply to complex situations associated with life-limiting cancer.  Second, surrogates may 
also be challenged to make the “right” decision in cases where opposing goals and preferences 
21 
must be balanced (see for example, Fried et al., 2009).  For example, patients may communicate 
conflicting information to the surrogate, stating they want to exhaust all possible measures to 
prolong life but also want to be kept comfortable at the EOL. 
 These complexities may explain why having access to the patient’s AD or having a 
conversation with the patient regarding EOL preferences has not resulted in congruence between 
the patient wishes and the surrogate decision making (Coppola et al., 2001; Ditto et al., 2001; 
Hare, Pratt, & Nelson, 1992; Hines et al., 2001; Marbella, Desbiens, Mueller-Rizner, & Layde, 
1998; Ouslander, Tymchuk, & Rahbar, 1989; Shalowitz, Garrett-Mayer, & Wendler, 2006; 
Uhlmann, Pearlman, & Cain, 1988; Zweibel & Cassel, 1989).  For example, of the 250 patient-
surrogate dyads interviewed by Hines et al. (2001), 63% of the patients and their surrogates 
agreed the patient had informed the surrogate of his or her preferences, and 33% of the patients 
reported having had more than five conversations with their surrogate.  However, having more 
conversations about EOL issues did not increase surrogates’ understanding of patients’ specific 
preferences or values (Hines et al., 2001).    
Timing 
 Patients with life-limiting illness and their caregivers and health practitioners have 
disparate views about how, with whom, and when discussions about EOL issues should be 
initiated (Clayton, Butow, Arnold, & Tattersall, 2005).  Contrary to guidelines for providers to 
discuss prognoses and realistic expectations with patients and their families (NCCN, 2010), 
findings from a survey involving approximately 5,000 physicians indicated many physicians 
delayed having EOL discussions until all nonpalliative treatments were exhausted or the patient 
raised the subject (Keating et al., 2010).  
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Research To Improve Patient-Surrogate Dyadic Congruence  
 When patients cannot exercise their autonomy over medical care, decisions must be made 
for them on the basis of the substituted judgment standard.  Most studies on this topic present 
hypothetical scenarios and estimate concordance or percent agreement between the patient’s 
stated preference for EOL care and the surrogate’s understanding of the patient preferences for 
each scenario.  Percent agreement represents how closely surrogates can approximate patient 
decision making using substituted judgment.  
 Several studies have demonstrated that surrogate decision makers are not able to 
represent the patients’ wishes accurately (Hare et al., 1992; Uhlmann et al., 1988; Zweibel & 
Cassel, 1989).  For example, Uhlmann et al. (1988) studied elderly outpatients to determine 
spouses’ awareness of patients’ preferences for CPR or CPR plus ventilator following cardiac 
arrest in context with varying prognoses and health conditions.  Although more than 75% of the 
spouses believed their predictions of patients’ preferences were accurate, accuracy did not 
exceed that expected due to chance alone.  Spouses significantly (p < 0.05) overestimated 
patients’ preferences for resuscitation in the CPR and ventilation situations.  These results 
suggest that spouses often do not understand patients’ preferences and are unlikely to provide 
congruent substituted judgment when faced with decisions about life-sustaining treatments.   
 A study conducted by Zweibel and Cassel (1989) examined the ability of physician-
selected surrogates to use substituted judgment for older single or widowed patients by 
examining a broader array of life-sustaining treatments than studied by Uhlmann and colleagues.  
(Physicians typically select a family member to act as a surrogate decision maker when a patient 
is older and single or widowed.)  The study aims was to examine surrogates’ ability to accurately 
reflect patient treatment choices when surrogates were not specifically directed to use substituted 
23 
judgment.  Fifty-five patient-surrogate dyads were separately presented with five hypothetical 
case vignettes describing the following scenarios: CPR and mechanical ventilation for patients in 
coma, receiving chemotherapy in end-stage cancer, patients’ inability to communicate with the 
health care practitioner, amputation in a demented elderly man, and tube feeding of a woman 
who refused to communicate with her doctors. For each scenario, surrogates were asked, “What 
would you tell the doctor to do?”  Differences in patient - surrogate pairs revealed opposing 
decisions ranging from 24% for tube feedings up to 44% and 50 %, respectively, for 
resuscitation and chemotherapy (Zweibel & Cassel, 1989).  
 Hare et al. (1992) used a method similar to that used by Zweibel and Cassel (1989) to 
examine patients and their self-selected surrogates.  However, they modified the vignettes used 
by Zweibel and Cassel to address the possibility that the vignettes about tube feeding and 
amputation were misinterpreted by study participants.  The modifications included the following 
contextual information: Patients’ current age was reported.  Tube feeding was based a patient 
who was in a permanent coma. Amputation was presented as a life-extending treatment and not 
solely as a means of pain control.  They also directed the surrogates participating in the study to 
use a substituted judgment standard, choosing a treatment the patients would choose.  The 
sample included 50 patient-surrogate dyads with a range of ages, which allowed examination of 
possible age differences in patient-surrogate decisions.  As measured by the kappa coefficient 
statistic, surrogates did not achieve statistically significant patient-surrogate dyadic congruence 
for any of the treatment decisions (Hare et al., 1992).  Similarly, when the preferences of elderly 
patients in a nursing home facility were compared with their closest relative and nursing home 
staff (i.e., a nurse, social worker, and physician), surrogates were found to not be significantly 
better than chance at predicting patients’ treatment preferences (Ouslander et al., 1989).  
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 Seckler et al. (1991) assessed dyadic congruence of 70 patient-family surrogate pairs 
regarding the resuscitation preferences of competent elderly outpatients.  They extended previous 
work (Ouslander et al., 1989; Uhlmann et al., 1988; Zweibel & Cassel, 1989) by including an 
assessment of the patients’ comprehension of the meaning of the hypothetical interventions they 
were asked to consider.  Patients were presented in person with three hypothetical CPR situations 
under two health status circumstances: current health and moderate dementia.  Family surrogates 
were given the same situations and questionnaires over the phone.  Though few pairs of patients 
and surrogates had previously discussed medical care preferences, 87% of the patients predicted 
that family members would accurately represent their wishes.  Concordance between family 
members and patients was statistically significant, but the obtained kappas (0.27 and 0.30, 
respectively) indicated less than moderate strength of agreement (kappa > 0.4 is considered 
moderate; Cohen, 1960).  Moderate agreement should be the minimum percent agreement 
required of surrogates when making serious EOL decisions on behalf of patients under the 
substitute judgment standard.      
 One criticism of these studies (Hare et al., 1992; Seckler et al., 1991; Uhlmann et al., 
1988; Zweibel & Cassel, 1989) is that patients and surrogates were asked about patient 
preferences when the patients were not critically ill.  Asking about preferences for hypothetical 
situations of deteriorating health that patients have yet to experience fails to characterize the 
decisions of patients and surrogates who are actually facing serious and complex choices.  
Research suggests that preferences for life-sustaining medical treatment can be unstable over 
time and highly dependent on the specific situation (Fried et al., 2006; Hawkins, Ditto, Danks, & 
Smucker, 2005).  Because of the difficulty anticipating all of the situations patients may face 
(Winzelberg et al., 2005), EOL decisions expressed during a period of relative health may not be 
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applicable during a subsequent period of illness or incapacity (Fried et al., 2006).  To investigate 
if difficulty imagining a decline in health was a limitation, Layde et al. (1995) evaluated the 
congruence of more than 1,000 patient-surrogate dyads when patients were hospitalized and 
seriously ill. Because of the severity of patients’ illness and anticipated 6-month survival rate of 
50%, Layde et al. were able to evaluate actual CPR preferences in light of the patients’ current 
health status.  Within pairs, the overall agreement rate with respect to CPR decisions was 74%.  
For patients who did not want to be resuscitated, however, 50% of the surrogates did not reflect 
the patient’s wishes.  
 There is some evidence indicating that surrogates who discuss patient preferences 
beforehand have improved patient-surrogate dyadic congruence (Ouslander et al., 1989; 
Sulmasy, Haller, & Terry, 1994; Sulmasy et al., 1998).  A pilot study of 50 general medical 
patients found that patient-surrogate dyadic congruence was positively associated with 
discussion between patient and surrogates (Sulmasy et al., 1994).  Building on this connection, 
Sulmasy et al. (1998) conducted cross-sectional paired interviews with 250 patients with 
terminal diagnoses and their surrogates to determine what factors are associated with higher 
patient-surrogate dyadic congruence.  On average, surrogates made correct predictions in only 
66% of instances.  Accuracy was higher for the permanent coma scenario than for scenarios of 
severe dementia or coma with small chance of recovery (p = 0.001).  The accuracy of substituted 
judgments was positively associated with the patient having spoken with the surrogate about 
EOL issues.  Age, ethnicity, marital status, religion, and ADs were not associated with accuracy.  
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Efforts to Improve Patient-Surrogate Communication 
 A number of intervention studies have evaluated how to increase patient-surrogate 
communication to promote congruence so that surrogates adequately understand patients’ 
preferences to guide patients’ EOL treatment preferences. Interventions to improve patient-
surrogate communication have included educational interventions, conducting values histories, 
and having a trained facilitator engage both patients and surrogates in ACP.  
Educational Interventions 
 Hare and Pratt (1993) evaluated the effectiveness of two educational programs: a 
workshop delivered in a classroom (instruction style) and a home study program (written 
materials).  The objectives of the educational programs were to increase communication about 
EOL decisions and to increase patient-surrogate dyadic congruence.  Fifty patient-surrogate 
dyads were presented with five hypothetical scenarios adapted from those used by Zweibel and 
Cassel (1989).  Prior to receiving the intervention, patients and surrogates were asked to 
independently make treatment decisions based on what the patient would want for himself or 
herself.  Study participants self-selected to participate in either the evening workshop or the 
home study.  Participant reports about treatment decisions were obtained 6 weeks after each 
program was completed.  Participants who elected to attend the workshop had significantly 
higher preintervention congruence scores compared to those who selected the home study 
program.  When age and preintervention scores were held as covariates, no significant 
differences were found on the postintervention agreement scores according to form of 
educational intervention.  In addition, no significant difference in pre- and postintervention 
agreement was found within groups.  Overall, the educational workshop program appeared to 
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have a somewhat more positive impact than did the home study program.  Neither program, 
however, significantly increased the agreement on difficult medical decisions (Hare & Pratt, 
1993).  
 The SUPPORT initiative (The SUPPORT Principle Investigators, 1995) consisted of an 
intervention designed to improve communication and ultimately agreement between patients and 
their surrogates.  A major hypothesis of SUPPORT was that accurate information and better 
communication would decrease the frequency of unwanted life-sustaining treatments.  The study 
was conducted in two phases in five teaching hospitals.  Phase I was a baseline observational 
study, and Phase II was a block-randomized clinical trial of an intervention intended to improve 
medical decision making and outcomes for seriously ill hospitalized patients (The SUPPORT 
Principle Investigators, 1995).  Using information gathered during Phase I, the investigators 
developed an intervention to improve communication and understanding during the decision-
making process and facilitate advance planning of treatment options.  Nurses were trained to 
assist and facilitate communication with the 2,652 patients who received the intervention. The 
findings revealed a failure to honor patients’ EOL preferences. The design of SUPPORT served 
as the baseline for several other investigations.  
 As an extension of SUPPORT (The SUPPORT Principal Investigators, 1995), Marbella 
et al. (1998) investigated whether nurses who spent extra time with patient-surrogate dyads to 
explain and answer questions about the patient’s prognoses and potential treatment increased 
dyadic congruence about the patient’s treatment preferences.  The treatment group included 386 
dyads, and the control group was comprised of 331 dyads.  No significant differences in dyadic 
congruence were found between the two groups. Hiltunen, Medich, Chase, Peterson & Forrow 
(1999) analyzed narratives written by SUPPORT nurses describing the  difficult decisions  
28 
seriously ill patients  near the end of their  lives face, and the experience of dealing with those 
decisions. The burden and complexity of family decision making emerged as a major theme. 
This analysis revealed that for successful ACP patients, families and providers should jointly 
discuss the patient’s values and EOL wishes. Marbella et al.’s intervention may not have been 
effective because it did not include a values history.  
Values History and Facilitated ACP 
 A values history is a specialized AD form that allows a patient to clarify their health-
related values and goals and communicate these values and goals to their surrogates. The 
surrogate is then able to select treatment choices based on the patients’ values and goals. This 
differs from a standard AD in that it asks patients to focus on clarifying their value- related 
reasons for specific treatment choices (Doukas & McCullough, 1991).   
Patients and surrogates also seem to agree about the benefit of a values discussion. The 
utility of a values history is supported by a longitudinal study with 337 patient-surrogate dyads 
that completed interviews and questionnaires.  Over half of patients (57%) and surrogates (67%) 
believed the best approach to documenting preferences was one that included both written 
requests and verbal communications with surrogates. Of those who did not choose both methods, 
more believed that verbal communication was the best approach. Most of the patients and 
surrogates who desired a written request, (50% and 44%, respectively) preferred one that 
contained only statements about values or goals (i.e., religious beliefs, importance of maintaining 
cognitive functioning) for care that patients would want guiding medical decisions. Fewer 
patients and surrogates desired an AD that included both value statements and precise treatment 
direction, and fewer still preferred one that omitted value statements and included only precise 
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directions regarding specific medical treatments (Hawkins et al., 2005). Similarly, in a 
qualitative study, patients and surrogates reported that facilitated discussions that identified 
values and discussions specific to health status or actual decisions that might need to be made 
were more effective than a discussion about hypothetical situations without facilitation (Karel, 
Powell, & Cantor, 2004).  
Matheis-Kraft and Roberto (1997) conducted a randomized control trial to investigate 
whether prior discussions between elderly female patients and their family member surrogates 
were more effective if they included discussion of patients’ personal values. A list of 23 value 
indicators and ten common EOL scenarios with three variations each (i.e., a total of 30 scenarios) 
were used to stimulate discussions and prioritize values. The three variations for each of the ten 
EOL scenarios were as follows: the patient’s current state of cognitive functioning, the patient as 
permanently confused, and the patient in permanent coma. Patients in the experimental group 
were asked to choose from the list of value indicators (i.e., independence, burden, dignity, fear, 
comfort) that were most influential to her medical decision making and to discuss why the 
selected value was important to her.  The surrogate was instructed to consider the values that his 
or her dyadic partner discussed. The experimental group did not have statistically higher 
agreement than the control group in 27 of the 30 situations using kappa. Using percent 
agreement, which is the best benchmark for assessing surrogates’ understanding of patient 
preferences, the experimental group only had better patient-surrogate congruence in 11 of the 30 
situations. Although the values history helped patients begin to communicate important 
information for EOL planning, it was not sufficient (Matheis-Kraft & Roberto).          
 Another trial evaluating the benefit of including a values history also yielded 
disappointing results. Ditto et al. (2001) tested various ADs with and without a values history as 
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part of an investigation to determine whether discussing the AD with the surrogate increased 
patient-surrogate dyadic congruence about patients’ EOL preferences.  None of the interventions 
produced significant improvement in congruence.  
 In contrast a study that included a trained facilitator in addition to a values history had 
more promising results. This study was conducted in Spain and evaluated patient-surrogate 
dyadic congruence in two intervention groups and in a control group;  an AD containing a values 
history, two educational sessions guided by a trained nurse or a control group who had neither an 
AD nor participated in the educational sessions (Barrio-Cantalejo et al., 2009).  Congruence in 
the control group and the group without facilitation was comparable. However, congruence 
between the dyads who received the facilitated educational sessions was significantly higher than 
it was in the control or AD groups. This finding underscores the benefit of having a trained ACP 
facilitator.  
 The promise of facilitated discussions between patients and surrogates that include 
patient values has led to the focus more on ACP as a process during which patients explore, 
discuss, articulate, and document their preferences rather than on ADs alone (Emanuel, von 
Gunten, & Ferris, 2000). This new focus is also consistent with evidence that suggests that EOL 
conversations should focus less on specific medical treatments a patient would or would not want 
and more on aspects of the patient’s specific health status that are of particular importance to the 
patient.  For example, patients may be more concerned about pain, mental deterioration, or 
physical dependency at EOL than whether they should be resuscitated (The President’s Council 
on Bioethics, 2005).  ACP that is customized to the patients’ health condition and guides patients 
to express EOL wishes so that their surrogates are able to understand their values may be most 
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effective (Bingley et al., 2006; Fried, Bullock, Iannone, and O’Leary, 2009; Matheis-Kraft & 
Roberto, 1997; Rosenfeld et al., 2000).   
 In summary, if patients’ EOL wishes are to be honored, patient-surrogate dyadic 
congruence must be improved.  The relatively high rate of discrepant decisions between patients 
and surrogates in the studies described above underscores the importance of effective patient-
surrogate communication before the patient’s medical condition renders him or her unable to 
make their treatment preferences known.  Conclusions across studies that have explored 
strategies to improve patient-surrogate dyadic congruence suggest that the most successful 
interventions include the following components: patients and surrogates engage in a process of 
exploring values and goals (Hawkins et al., 2005; Hiltunen et al., 1999; Sudore et al., 2008; 
Sulmasy et al., 1994; Sulmasy et al., 1998); patients’ values and goals are explicitly 
communicated to their surrogate (Barrio-Cantalego et al., 2009; Bingley et al., 2006; Hawkins et 
al., 2005; Karel et al., 2004; Levi et al., 2010; Mathies-Kraft & Roberto, 1997; Rosenfeld et al., 
2000; Sulmasy et al., 1998), patient-surrogate discussions are facilitated by a trained professional 
and are specific to the health problems patients with a  particular illness are likely to encounter 
(Barrio-Cantalego et al., 2009; Fried et al., 2009; Hagerty et al., 2005; Karel et al., 2004), and the 
process occurs early and is modified as the patients’ illness progresses (Hiltunen et al., 1999; 
Sulmasy et al., 1994; Sulmasy et al., 1998).  The Respecting Choices® DS-ACP intervention 
encompasses these strategies.    
Respecting Choices® Disease Specific Advance Care Planning 
 Respecting Choices® DS-ACP is an interventional interview conducted with patients and 
surrogates that is designed to promote the kind of in-depth dialogue central to ACP (Briggs & 
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Hammes, 2008).  The method by which Respecting Choice DS-ACP generates the AD document 
(a Statement for Treatment Preferences) provides opportunities for accurate expression of the 
patient’s wishes.  Each element of the Respecting Choices DS-ACP interview is a venue for the 
patient and surrogate to reflect on the patient’s goals and values and discuss how these goals and 
values can direct treatment decisions.  The final AD document is not only intended to help 
patients communicate specific treatment preferences, but also to help surrogates understand 
patients’ overarching priorities when unanticipated situations arise.  
 The Respecting Choices® DS-ACP has been evaluated for promoting patient-surrogate 
congruence of shared decision-making outcomes and decisional conflict with patients with 
chronic illnesses (Briggs et al., 2004), geriatric patients (Schwartz et al., 2002), and adolescents 
with HIV (Lyon et al., 2009).  All of these studies found the Respecting Choices DS-ACP 
intervention significantly improved congruence between surrogates and patients in understanding 
the patients’ preferences and reduced the surrogates’ decisional conflict.  Respecting Choices 
DS-ACP has also been evaluated in a multisite randomized controlled trial with outpatients 
diagnosed with congestive heart failure or congestive respiratory failure (Kirchhoff et al., 2010) 
and a randomized controlled trial study with 309 elderly hospitalized patients in Australia 
(Detering, Hancock, Reade, & Silvester, 2010).  In both studies, surrogates in the intervention 
groups demonstrated a significantly higher degree of understanding of patients’ goals than did 
surrogates in the control group (Detering et al., 2010; Kirchhoff et al., 2010).  EOL wishes were 
also respected significantly more in those who had died in the intervention group (25 of 29) than 
those who had died in the control group (8 of 27; Detering et al., 2010).   
 A unique feature of Respecting Choices® DS-ACP is its focus on  training professionals 
in the communications skills needed to facilitate a discussion that engages patients and 
33 
surrogates about the importance of ACP, the effects and meaning of the illness, and expectations 
for future care (Briggs & Hammes, 2008; Briggs et al., 2004; Westley & Briggs, 2004).  The 
following components are included in the communication skill training: exploring past 
experiences, fears, and concerns; clarifying medical information and disease complications; 
assisting in weighing the benefits and burdens of life-sustaining interventions; and setting 
guidelines on what it would mean to live well as health conditions change.   
 Respecting Choices® DS-ACP has not been evaluated in patients with life-limiting 
cancer. Life-limiting cancer may present more complex EOL issues than the issues involved with 
chronic illness or congestive heart or respiratory failure. Although Respecting Choices® DS-
ACP is tailored to complications and life sustaining treatments that are specific to a given 
disease, the same theoretical framework underlies every Respecting Choices® DS-ACP 
intervention. 
Theoretical Framework 
The Respecting Choices DS-ACP intervention is based on the social science theory of the 
representational approach to patient education (Donovan & Ward, 2001), which was derived 
from elements of the common-sense model (Diefenbach & Leventhal, 1996; Ward, 1993).  The 
core tenet of the representational approach is that effective patient education is most likely to 
occur when patients’ knowledge and beliefs are elicited before new information is provided 
(Donovan & Ward; Diefenbach & Leventhal).     
Donovan and Ward (2001) proposed that patients be given a representation of their 
illness according to five dimensions: identity, cause, timeline, consequences, and cure/control.  
Identity pertains to how a person describes and experiences his or her symptoms or health 
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problem.  Cause pertains to the individual’s beliefs about the origin of their health problem.  
Timeline relates to beliefs about the length of the illness. Consequences are ideas about the short- 
and long-term outcomes of the problem.  Cure or control are beliefs about the extent to which 
one can control or cure a health problem.  
According to Donovan and Ward (2001), the representational approach is a fluid 
interview process that moves back and forth between these five dimensions.  The goal of the 
approach is to maximize opportunities for patients to reflect and comment on their own ideas 
about their illness according to identity, cause, timeline, consequences and cure/control as well 
as to provide new information about these illness dimensions when patients are most ready to 
hear it.  Opportunities for self-reflection provide conditions in which conceptual change can 
occur throughout the entire process and provide patients with a cognitive framework for 
interpreting and processing new information about their illness (Donovan et al., 2007).    
Fins et al. (2005) and Maltby and Fins (2003) proposed a covenantal model of ACP 
whereby patients with life-limiting cancer and their surrogates can explore complex EOL 
situations that lack clear choices.  A covenantal relationship between patient and surrogate is 
sustained by trust and understanding. Trust and understanding can be the greatest sources of 
guidance for surrogates facing EOL situations that are clinically and morally ambiguous and lack 
clear choices, (Maltby & Fins). 
Respecting Choices is designed to offer guidance and trust.  The Respecting Choices® 
DS-ACP requires developing or solidifying this covenantal relationship as part of helping both 
patients and surrogates understand that complex situations may arise and necessitate an 
interpretation of the patient’s judgment by the surrogate.  The underlying premise is that 
surrogates who have a reservoir of discretionary trust and receive adequate guidance from 
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patients are able to act ethically and effectively.  An empowered surrogate is less likely to be 
burdened by guilt and emotional pain that can result when making life and death decisions (Fins 
et al., 2005).  
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CHAPTER 3: METHODS 
Research Design 
The design for this study was a Phase I clinical trial.  A Phase I clinical trial was selected 
instead of a randomized control trial because of the risk of not providing an intervention that has 
demonstrated benefits with other study populations. A Phase I clinical trial design is appropriate 
for initial investigation of the impact of the Respecting Choices® ACP intervention with patients 
with life-limiting cancer and their surrogates.  Measures were administered before and after the 
intervention.  Anecdotal information was collected to evaluate patients’ and surrogates’ 
satisfaction with the intervention and its timing. 
Independent and Dependent Variables 
The independent variable in the study will be time (pre and post the Respecting Choices® 
DS-ACP intervention). Dependent variables in the study will be patient-surrogate congruence, 
patients’ anxiety, and decisional conflict.    
Population, Sample, and Setting 
The sample included patients and their surrogate decision makers who have received a 
diagnosis of life-limiting cancer or whose previously treated cancer has progressed or 
reoccurred.  For the purpose of this study the term life-limiting cancer is defined as an initial or 
recurrent diagnosis of advanced cancer or invasive cancer. Advanced cancer is cancer that has 
grown beyond the organ in which it first started or affects a vital organ that cannot be removed. 
Invasive cancer is when cancer cells have penetrated the original layer of tissue (ACS, 2010).       
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Sample Selection 
Eligibility and Exclusion Criteria 
To qualify for inclusion in the study, both the patients and their surrogate decision 
makers needed to be 21 years of age or older, speak and read English as their primary language 
and have the capacity to understand the information on the Statement of Treatment Preferences 
for Patients with Life-Limiting Cancer Form, a form which patients could choose to serve as 
their AD if they participated in the study (see Statement of Treatment Preferences for Life-
Limiting Cancer in Appendix A).  Silberfeld, Nash, and Singer’s (1993) Verbal Assessment 
Questions (Appendix B) were used to screen for participants’ capacity to understand the nature 
and purpose of the Statement of Treatment Preferences for Life-Limiting Cancer Form and the 
role of health care surrogates.  The principal researcher administered the questions verbally prior 
to the intervention. The patients were required to assign a surrogate who would participate with 
the patient in the Respecting Choices® DS-ACP intervention.  The surrogate could be a friend, a 
relative, or other known person who agreed to perform the role of surrogate.  Participants were 
excluded from the study if they did not have a surrogate who was willing to participate in the 
intervention.  
Recruitment 
The initial intent was to recruit participants through partnership with area oncologists. 
However, consistent with the literature (see for example, Astrow et al., 2008; Baile, et al., 2002; 
Bradley et al., 2001; Curtis et al.,2000; Kish et al., 2000; Tung, 2009; Walling et al., 2008; 
Yedidia, 2007), it was difficult to gain consent from practicing health care professionals. More 
specifically, over fifteen local practices were contacted, including oncologists, primary care, 
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internal medicine, and hospice. Only one of these contacts led to a referral to potential study 
participants. Additional networking led to the Volunteers in Medicine Clinic (VIM), who eagerly 
embraced the opportunity to provide this ACP intervention to patients under their care who were 
dealing with life limiting cancer. The VIM clinic serves the health and wellness needs of 
community members who are not eligible for any government programs, are not covered by 
insurance and have income below 200 per cent of the poverty level. Medical care is provided by 
volunteer medical personnel working in concert with existing medical resources in the 
community, including oncologists and cancer centers. 
The Health Insurance Portability and Accountability Act (HIPAA) precludes the 
researcher from screening or directly approaching potentially eligible patients. Therefore, the 
researcher presented selected VIM referral providers with inclusion and exclusion criteria and a 
verbal script to ask patients who met the eligibility criteria if they were interested in receiving 
additional information about the study. If a patient was interested in obtaining additional 
information, he or she was given a copy of an introductory letter written by the researcher that 
described the study (Appendix C). Interested patients who agreed to be contacted provided their 
preferred contact information on a card that accompanied the introductory letter.   
The researcher contacted the potential participant(s) via their requested method, 
explained the study, confirmed that the patient had a surrogate decision maker, and explained the 
informed consent procedure. If the potential participant(s) agreed to participate, a meeting was 
scheduled to obtain informed consent (see Informed Consent and Appendix D), and enroll the 
patient and the surrogate. Study participation occurred at this same appointment, following 
consent. Special attention was given to ensure that participation was completely voluntary. In 
other words, that all contact with potential study participants was free of coercion and undue 
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influences (National Institutes of Health [NIH] 1979). Potential participants were assured that 
participation was completely their choice and that not participating would in no way affect their 
care. Potential participants who self-reported being uncomfortable with or not being ready to 
participate in the Respecting Choices intervention were provided with contact information in the 
event that they changed their mind or wanted more information.  
Although 12 eligible participants from VIM initially agreed to participate in this ACP 
intervention, only five were able to do so due to the severity of their life limiting cancer. 
However, snowball recruitment provided an additional nine eligible recruits for the intervention. 
Three of the five participants who were recruited from VIM and received the intervention 
referred people with life-limiting cancer based on their satisfaction with the intervention. 
Participants referred by participants from VIM also provided referrals, including patients they 
met in cancer support groups or during treatment, for example during infusion therapy sessions.  
These potential participants were given the introductory letter (Appendix C) by the person 
referring them to the study. Interested individuals who agreed to be contacted gave verbal 
consent to their referral source and provided their preferred contact information on a card that 
accompanied the introductory letter.  After receiving permission, the investigator contacted 
potential participants and followed the recruitment and informed consent sequence as previously 
described.  
Sample Size, Power, and Significance 
The initial plan was a sample size ranging from 15-34 depending on effect size. The 
upper number, 34 dyads, was based on detecting a medium effect size of .50, assuming a power 
of .80, and an of .05 in analyses involving the paired t-test (Faul, Erdfelder, Buchner & Lang, 
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2009). However, analyses were conducted once data were obtained from 15 dyads to determine 
if the study effect sizes were large enough (.80) to be detected with a smaller sample. 
Recruitment ceased once it was determined that 15 dyads provided sufficient power (.80) to 
detect a significant effect.    
Setting 
The setting for the proposed study was at the VIM clinic or the participant’s home. 
Participant(s) were asked to select the time and location that they preferred. 
Ethical Considerations 
Based on findings from numerous studies with other study populations, (Briggs et al., 
2004; Detering et al., 2010; Kirchhoff et al.,2010; Lyons et al., 2009; Schwartz et al., 2002; Song 
et al., 2005), there is strong evidence that the Respecting Choices® DS-ACP intervention is 
superior to traditional approaches for AD completion. Thus, all participants in this study received 
the intervention.  Delivering the intervention to everyone was based on two principles--the 
wellbeing of each individual research participant taking precedence over all other interests and 
access to the best available standard of care (World Medical Association, 2008)--  
 In addition to following procedures for informed consent (see below), special attention 
was given to the sensitive nature of discussing EOL issues with patients and their surrogates. 
Extra attention was given to providing patients and surrogates with adequate study information 
to support making an informed decision about study participation. The guidelines outlined in 
Eligibility and Exclusion Criteria to assess the capacity to participate in the intervention and 
complete the AD were followed to decrease potential misunderstandings about the intervention 
and study procedures. Situations that might cause distress or burden were carefully considered 
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and managed during the intervention (NIH, 1979; McMillan & Weitzner, 2003). For example, 
the intervention includes a step to ensure that specific questions or concerns that arise during the 
intervention are discussed with the study participant and, if needed and with participant’s 
permission, referred to the individual’s health care provider (see Stage 6 of the intervention in 
Respecting Choices® DS-ACP Interview and Appendix E).  Procedures were in place in the 
event additional resources were identified during the interview.  
 Additionally, data collection and the intervention were designed to minimize risks and 
burden.  The intervention was scheduled to occur at a time and place that was most convenient 
for the participants.  All data collection instruments were selected to collect only essential data 
and were administered at one visit by one researcher to ensure consistent application of the 
instruments.  
Informed Consent 
Participants were provided with a description of the study, its purpose, and why they 
were selected. The participants were given a description of what they would be asked to do, how 
long it would take, and information about the potential risks and benefits of participating.  They 
were provided with a statement that participation was completely voluntary and that they could 
withdraw at any time without repercussions.  Participants were provided with the researcher’s 
contact information and instructed to contact her if any questions were to arise before or during 
the study.  The participants were also provided with a name and contact information of another 
person they could call if they have any complaints or concerns about the research.  A copy of the 
informed consent form and its explanatory text are included in Appendix D. 
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A copy of the Statement for Treatment Preference For Life-Limiting Cancer Form (see 
Appendix A) was given to the participants for their records.  No names or identifying 
information were written on the data collection forms.  Instead, the names of patients and 
surrogates were replaced by numbers randomly assigned to each dyad.  Only one person, the 
researcher conducting the study, collected and stored the data. The participants were assured that 
all data would be kept confidential.  
Permission to proceed was sought and secured from the Institutional Review Board (IRB) 
associated with the proposed research.  The investigator first secured approval to proceed from 
the University of Central Florida’s IRB before launching the study.   
Intervention 
Respecting Choices® DS-ACP Interview 
The Respecting Choices intervention is delivered as a one-time interview that provides a 
structured approach for assessing the patient’s and his or her surrogate’s representation of the 
patient’s illness, beliefs, goals, and values. The interview also explores experiences that may 
have an impact on health care decision making.  The intended goal of this intervention is to help 
patients make informed choices that are understood by the surrogate.  In the event there is a need 
for an additional meeting or follow-up discussion after the patient speaks with their healthcare 
provider, a follow up meeting is scheduled.     
The six key stages of the Respecting Choices interview are as follows: (1) assess illness 
beliefs, goals, and values; (2) explore experiences; (3) explain the purpose of advance care 
planning; (4) clarify goals for life-sustaining preferences; (5) summarize what was learned; and 
(6)  develop a follow-up plan.  Details on these six stages are provided in Respecting Choices® 
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DS-ACP Interview (see Appendix E). The interview takes approximately 90 minutes. The 
researcher is a trained Respecting Choices ACP facilitator and delivered the intervention. The 
researcher took brief handwritten notes during the intervention to develop a follow-up plan for 
participants.  The researcher documented anecdotal information as field notes after each 
interview.  
Respecting Choices® DS ACP is a standard intervention with protocols that were applied 
consistently in a predetermined sequence.  Fidelity to the intervention was maintained by its 
being administered by one trained facilitator. Any deviation to protocol that occurred was 
documented in a study log. The only deviation to protocol pertained to the recruitment method as 
described above (see Recruitment).   
The Respecting Choices® DS ACP intervention uses disease specific scenarios and these 
scenarios are integrated into the Statement of Treatment Preferences Form (see Appendix A).  
Development of these scenarios was guided by the research of Fried et al. (2002), who noted that 
the treatment decisions of people with life-limiting illness are influenced by treatment burden, 
treatment outcome, and the likelihood of the outcome. Patients are asked to verbalize their goals 
for life sustaining treatments in clinical scenarios that include the following: low survival but 
high burden; high survival with functional disability; and high survival with cognitive disability 
specific to the illness trajectory of life-limiting cancer.      
Respecting Choices Facilitator Training 
Health care professionals who wish to administer the Respecting Choices® DS-ACP 
intervention materials are required to complete training.  The training incorporates Weiner and 
Cole’s (2004) conceptual approach, which addresses specialized skills of shared decision making 
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specific to advanced illness and EOL in addition to general patient-centered communication 
skills.  Facilitators learn key communication techniques, such as exploring the meaning of words 
and phrases, listening, paraphrasing, clarifying, affirming and reaffirming, and displaying 
empathy.  These communication techniques are integrated into the delivery of the Respecting 
Choices intervention and allow for the following: in-depth expression by the patient and 
surrogate; increasing patient and surrogate knowledge of the patient’s illness; clarifying the 
patient’s goals, values, and beliefs, thereby informing the surrogate; creating shared decision 
making as an approach; and creating an environment of trust and openness (Briggs & Hammes, 
2008/2010). 
The researcher completed the Respecting Choices facilitator training program in 
February, 2010.  In addition to instruction in communication techniques, the 2-day competency-
based training program included online learning modules, review of relevant literature, 
demonstrations, and practice scenarios to support the achievement of expected outcomes. The 
training also included the researcher demonstrating delivery of the Respecting Choices® DS-
ACP interview via videotaping a role play and receiving constructive feedback from Respecting 
Choices faculty (Briggs & Hammes, 2008).  As a final step in the ACP facilitator training 
protocol, the researcher completed and submitted a second video role-play for evaluation prior to 
administering the intervention for this proposed study.  This final step culminated in certification 
and was completed prior to beginning recruitment of participants. 
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Instruments 
Sociodemographic Form  
Two versions of a sociodemographic questionnaire were administered: one for the patient 
and one for the surrogate (see Appendix F).  Both versions include age, gender, marital status, 
education level, income, religious affiliation, and patient-surrogate relationship.  The patient 
form also includes diagnosis, referral source (e.g., VIM Clinic, friend), housing status (where 
and with whom the patient lives), and a question about the patient’s perceived prognosis.  The 
surrogate form also includes a question about the surrogate’s perception of the patient’s 
perceived prognosis  
Statement of Treatment Preferences for Life-limiting Cancer 
The Statement of Treatment Preferences for Life-Limiting Cancer Form (see Appendix 
A) presents five clinical situations and clarifies goals for the patient’s preferences and assesses 
the surrogate’s understanding of the patient’s preferences in each of the clinical situations. The 
first four clinical situations describe the following cancer outcomes after a trial of treatment: a 
prolonged hospital stay with little chance of survival; a worsening of the cancer with a 2-3 month 
survival; a good chance of survival with functional impairment requiring 24-hour nursing care; 
and a good chance of survival with permanent cognitive impairment requiring 24-hour nursing 
care, respectively. The fifth situation requires CPR and has a poor outcome. After discussion and 
clarification of the meaning of each situation, the patient is asked to choose 1 of 2 options for 
each situation: “continue all treatment,” or “stop all treatment.”   
The Statement of Treatment Preferences was developed by Briggs & Hammes 
(2008/2010) and pilot tested with patients to assess participants’ understanding of the form prior 
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to its use in research settings (Hammes, 2001).  It has been used in research settings as a decision 
aid and documentation tool to promote understanding of likely situations that could occur in the 
future and express the patients’ goals of treatment in light of acceptable and unacceptable 
burdens and outcomes (Briggs et al., 2004; Detering et al., 2010; Kirchhoff et al., 2010; Lyons et 
al., 2009; Schwartz et al., 2002; Song et al., 2005).   
The Statement of Treatment Preferences is based on a modified version of the Emmanuel 
and Emmanuel Medical Directive, a reliable and valid means of both documenting patient wishes 
for EOL care and measuring the outcome of ACP interventions (Schwartz, Merriman, Reed & 
Hammes, 2004). Reliability assessment included internal consistency reliability across situations 
within and across treatments and situations and test-retest stability among patients with stable 
health (Schwartz et al., 2004).  Both types of reliability were high. 
Decisional Conflict Scale  
The DCS (see Appendix G) measures perception of uncertainty in choosing medical 
treatment options and factors contributing to uncertainty, such as lack of information, lack of 
clarity regarding personal values, and lack of support in decision making (O’Connor, 1995, 
updated 2005).  This instrument consists of 16 items and the following five subscales: Informed 
subscale (items 1-3), Values Clarity subscale (items 4-6), Support subscale (items 7-9), 
Uncertainty subscale (items 10-12), and Effective Decision subscale (items 13-16).  Items in 
each subscale are scored on a 5-point Likert-type scale from 0 (strongly agree) to 4 (strongly 
disagree). The DCS was designed to be self-administered.  
The DCS has been widely used to evaluate patients’ decisions regarding types of health 
care treatment (O’Connor, 1995).  Cronbach’s alpha for the total DCS ranged from 0.78 to 0.92 
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(Meropol et al., 2003; O’Connor et al., 1999; O’Connor & Jacobsen, 2007).  This instrument has 
been shown to have clinical utility, especially in situations in which patients are faced with 
complicated decisions.  Sample size in most studies is usually based on detecting effect size of 
0.30-0.40.  Scores lower than 25 are associated with implementing decisions; scores exceeding 
37.5 are associated with decisional delay or feeling unsure about implementation (Graham & 
O’Connor, 1995, updated 2005).   
Song and Sereika (2006) examined the reliability and the validity of the DCS when the 
tool was used to measure patients’ evaluations of the EOL decision-making process.  This 
evaluation used a combined sample of patients who had participated in two previous studies 
(Briggs et al., 2004; Song et al., 2005).  Song and Sereika, with one exception, found the DCS to 
have acceptable reliability and validity when used to assess EOL decision making.  The 
exception pertained to the weak relationship between the uncertainty subscale and perceptions of 
the modifiable factors contributing to uncertainty, such as ‘feeling the decision is easy to make’.   
They concluded that uncertainty is not a useful domain to measure when uncertainty is 
inevitable. Therefore, the original plan was not to use the uncertainty subscale (items 10, 11, and 
12) in this study. However, most of the obtained inter-item correlation among the Uncertainty 
items was higher than .30. Thus the Uncertainty subscale was included in this study.  
Spielberger State Anxiety Scale S-anxiety Scale   
The STAI is comprised of two separate self-report scales for measuring state and trait 
anxiety, but only the scale for State anxiety was used in this study (see Appendix G).  The State-
anxiety Scale (STAI Form Y-1) consists of 20 statements that evaluate the respondent’s feelings 
of apprehension, tension, nervousness, and worry right now—at the moment (Spielberger, 1983).   
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The STAI (Form Y-1 & Form Y-2) was designed to be self-administered and is reported to take 
approximately 6 minutes when used with college students and approximately 10 minutes when 
used with less-educated or emotionally disturbed persons (Spielberger, 1983).   
The S-anxiety Scale has been found to be a sensitive indicator of change in transitory 
anxiety experienced by clients and patients in counseling, psychotherapy, and behavior 
modification programs.  The scale has also been used extensively to assess S-anxiety induced by 
stressful experimental procedures and unavoidable real life stressors (Spielberger, 1983).    
In studies conducted by Spielberger (1983), the stability coefficients for Form Y-1 were 
based on two groups of high school students tested in classroom settings.  Test-retest intervals 
were 30 days (0.62 for males, 0.34 for females) and 60 days (0.51 for males, 0.36 for females).  
As would be expected for measures assessing change in anxiety resulting from situational stress, 
stability, as measured by test-retest coefficients, was low for the S-anxiety Scale. Internal 
consistency reliability ranged from 0.83-0.92 for S-Anxiety Scale (Weintraub & Hagopian, 
1990).   
Concurrent validity was supported by correlating the STAI with the Taylor Manifest 
Anxiety Scale and Institute for Personality and Ability Testing (IPAT) Anxiety Scale (0.79 to 
0.83 and 0.75 to 0.76, respectively).  Construct validity was determined by comparing like 
subjects under stressful and nonstressful situations (Derogatis & Wise, 1989).  The STAI has 
been successfully used with high school and college students (Gaudry, Vagg & Spielberger, 
1975; Spielberger, 1983), psychiatric patients (Spielberger 1983), medical and surgical patients 
(Cupples, 1991; Petersen, 1991; Weintraub & Hagopian, 1990; Wong & Bramwell, 1992; 
Zimmerman, Pierson, & Marker, 1988), obstetric patients (Annie & Groer, 1991; Pond & Kemp, 
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1992), the chronically ill (Gift, 1991), and the elderly (Fraser & Kerr, 1993).  The STAI is 
written at a fifth-grade level.  
Complete instructions are printed on the test form but may be modified to evaluate the 
intensity of the S-anxiety for any situation or time interval of interest.  For research purposes, the 
researcher can alter instructions for the S-anxiety Scale to focus on a particular time period 
(Spielberger, 1983). In this study, the specified time period was “right now.” 
To reduce response bias, such as the tendency to agree with positively worded items, half 
of the items are stated positively and half are stated negatively.  The scoring weights for the 
anxiety-absent items are reversed (see Appendix H).  Each STAI item is given a weighted score 
of 1 to 4.  A rating of 4 indicates the presence of a high anxiety level for 10 items and a high 
rating indicates an absence of anxiety for the remaining 10 items.  The scoring weights for the 
anxiety-absent items are reversed (for example, items marked 1, 2, 3, or 4 are scored 4, 3, 2, and 
1, respectively).  The anxiety-absent items for which scoring is reversed on the S-anxiety Scale 
are 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20.  To obtain scores, the weighted scores for 20 items are 
added together, taking into account the fact that scores are reversed for these items.  Scores can 
vary from a minimum of 20 to a maximum of 80 (Spielberger, 1983).   
Quality of Communication about End-of-life Care  
The Quality of Communication about EOL Care Form (see Appendix I) assesses the 
fidelity of the intervention by asking about patient and surrogate satisfaction with the overall 
quality of the intervention and the facilitator. The form has been utilized to evaluate the quality 
of communication regarding EOL treatment in studies between the patient and his or her health 
care provider and the patient and nurse providing the Respecting Choices® ACP interview 
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(Briggs et al., 2004; Curtis, Patrick, Caldwell, Greenlee, & Collier, 1999; Lyons, et al., 2009; 
Song et al., 2005).  This instrument consists of five questions: The first question asks if the 
patients’ treatment preferences are known (congruence). Question 2, 3 and 4 pertain to whether 
participants felt the interviewer truly cared about them, listened, and gave them enough attention 
during the discussion (interviewer fidelity). These four questions are rated on a scale of 1 (no) to 
3 (definitely yes).  The fifth question asks participants to rate the overall quality of the discussion 
(interview fidelity) on a scale of 1 (poor) to 5 (excellent). Use of this questionnaire among AIDS 
patients has yielded good internal consistency with a Cronbach’s alpha of 0.81 (Curtis et al., 
1999). In a study using the Respecting Choices® ACP intervention, the internal consistency 
reliability was 0.87 (Song & Sereika, 2006).   
Data Collection Procedure 
After IRB approval was received from the researcher’s university and referral sources, all 
eligible patient-surrogate dyads referred for study participation were provided with information 
about informed consent and requested to consent to participate (see Appendix D).   Participants 
who agreed to participate signed the informed consent form, a copy of which was returned to 
both members of the dyad and the original retained by the researcher.  Based on 
recommendations from prior studies (Ditto et al., 2001; Schwartz et al., 2002) in which 
transportation was a barrier to participating, participants were offered the choice of their home as 
the site of data collection.  Each patient-surrogate dyad was scheduled for one 90-minute 
Respecting Choices® DS-ACP interview by the researcher.  Prior to the interview, both the 
patient and surrogate were separated and requested to independently complete the appropriate 
Sociodemographic Data Form (see Appendix F), and Statement of Treatment Preferences for 
51 
Life-Limiting Cancer Form (see Appendix A).  Patients also completed the DCS (see Appendix 
G) and STAI (see Appendix H). Participants were instructed to respond according to how they 
felt immediately before the intervention.   
Next, the patient-surrogate dyads participated in the Respecting Choices® DS-ACP 
interview.  The six stages (see Respecting Choices DS- ACP Interview in Appendix E) were 
addressed in one 90-minute interview session.  Immediately after the interview, the patient and 
surrogate were separated.  The patient completed the STAI second time (post test) but this time 
the directions were to respond based on how he or she felt immediately after the intervention. 
After completing the second administration of the STAI, the patient was also asked to complete 
the Statement of Treatment Preference for Life-Limiting Cancer Form, the DCS and the Quality 
of Communication about EOL Care Form. The surrogate also completed the Statement of 
Treatment for Life-Limiting Cancer Form and the Quality of Communication about EOL Care 
Form (see Table 1). Participants were asked to write in a response to an additional question about 
whether they thought this was a good time to have this discussion. Some participants chose to 
write qualifying information about the best possible time.   
All forms were collected and stored by this researcher, as described in the section on 
Ethical Considerations.  The patient’s Statement of Treatment Preferences for Life-Limiting 
Cancer, as well as any written information about concerns or questions collected during the 
interview (e.g., questions the patient would like to discuss with his or her health care provider) 
were given to the patient.  
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Table 1. Data Collection Method by Time Pre-and Post- Intervention (Patients, Surrogate) 
 Pre Intervention Post Intervention 
      
Patient                                        Demographic Form (patient version) 
Statement of Treatment Preferences 
DCS 
STAI 
 
STAI 
Statement of Treatment Preferences 
DCS 
Quality of Communication Form 
Surrogate Demographic Form (surrogate version) 
Statement of Treatment Preferences 
Statement of Treatment Preferences 
Quality of Communication Form 
 
Data Analysis Plan 
Data were entered into SPSS version 18.0 for Windows for analysis.  Descriptive 
statistics were performed to describe the sample and included the frequencies and percentages, 
means, and standard deviations.  For categorical or nominal data, frequencies and percentages 
were conducted.  Means and standard deviations were calculated on interval/ratio data (Cronk, 
2006; Salkind, 2005).    
Research Question 1 
RQ1: Does the intervention increase congruence on the Treatment Preferences for Life-
Limiting Cancer Form (pretest versus posttest) between patient and matched surrogate?   
 To answer RQ 1, five 2x2 McNemar Chi-square tests were conducted to investigate 
whether the intervention increased congruence on the statement of treatment preferences for life-
limiting cancer form (pretest versus posttest) between patient and matched surrogate.  A pretest 
agree/disagree (0, 1) score and a posttest agree/disagree (0, 1) score were calculated for each 
patient-surrogate pair for each of the five situations.  One McNemar Chi-square analysis was 
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conducted for each situation to compare changes in patient-surrogate agreement pre and post 
intervention. The rows correspond to pretest congruence (disagreement, agreement) and the 
columns correspond to posttest congruence (disagreement, agreement).  A significant McNemar 
Chi-square test was interpreted as a significant change in the proportion of congruence over time.   
Research Question 2 
RQ2: Are there significant differences in the proportion of congruence observed for 
different situations at post test?   
To answer RQ 2, the Zar’s Multiple Comparison Test of Differences was conducted to 
investigate whether there are significant differences in the proportion of congruence observed for 
different situations on the Statement of Treatment Preferences for life-limiting cancer form at 
post test.    
Research Questions 3 and 4 
RQ3: Does the intervention reduce patients’ decisional conflict?   
RQ4: Does the intervention increase patients’ anxiety?   
A paired-sample t test was conducted to address both research questions 3 and 4.   The 
independent or grouping variable in both analyses was time (pretest versus posttest).  The paired-
sample t test is an appropriate statistical analysis when the two scores are repeated measures, 
such as in situations when the assessment is used as a pretest before an intervention and as a 
posttest after the intervention (Field, 2005).  The dependent variable in each analysis (decisional 
conflict, anxiety) was evaluated for presence of outliers and problems with normality prior to 
conducting the t-test.  Descriptive statistics (skew, frequency) were inspected to evaluate 
normality. All appropriate assumptions were met for analysis using the paired-sample t test.    
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Analysis Assessing Fidelity and Timing of Intervention 
Frequencies and percentages were conducted for the five items on the Quality of 
Communication about EOL Care Form to assess the fidelity of the intervention. “Yes” and “No” 
responses to the additional question about timing were tallied. Anecdotal comments about timing 
were content analyzed and summarized. 
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CHAPTER 4: RESULTS 
Descriptive Statistics 
Sample 
Thirty people participated in the study, 15 patients and 15 paired surrogates. Although 12 
eligible participants from VIM initially agreed to participate in this ACP intervention, only five 
were able to do so due to the severity of their cancer and/or reluctance to add to their surrogates’ 
burden. As previously discussed (see Recruitment), snowball recruitment provided an additional 
nine eligible recruits for the intervention.  
The demographic characteristics of the sample are presented in Table 2. All but three 
patients reported employment status as ‘not currently working due to their current illness’ or 
‘retired.’ As can be seen in Table 2, slightly more than half of the participants were 55 years of 
age or older (n = 8, 53.3%) and the majority of surrogates were younger than the patients (n = 9, 
60.0%).   The majority of surrogates were spouses of married patients (n=9, 60%); a spouse was 
the surrogate for all but one of the nine married patients (n = 8, 90%).  All patients reported some 
category of Christian as their religious background and almost half reported attending religious 
services at least once a month (n=6, 40%). Many participants were reluctant to report income but 
the five who were recruited from VIM were at least 200% below the poverty level.   
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Table 2. Socio-Demographic Characteristics 
 Patient Surrogate 
Demographic n % n % 
Age     
 54 years old or younger 3 20.0 9 60.0 
 55-59 years old 8 53.3 3 20.0 
 60 years old or older 4 26.7 3 20.0 
Gender     
 Male 6 40.0 3 20.0 
 Female 9 60.0 12 80.0 
Marital status     
 Single - - 1 6.7 
 Married 9 60.0 13 86.7 
 Divorced 5 33.3 - - 
 Widowed 1 6.7 - - 
 Domestic partnership - - 1 6.7 
Religious Affiliation current      
 Non-denominational Christian 10 66.7 8 53.3 
 Catholic 5 33.3 7 46.7 
How Often Attending Religious Services     
 Once a week or more 4 26.7 1 7.1 
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 Patient Surrogate 
Demographic n % n % 
 About once a month 2 13.3 5 35.7 
 Holy days and special occasions only 2 13.3 6 42.9 
 Never 3 20.0 1 7.1 
Patient Housing Status     
 Home 15 100 - - 
Education Level     
 High school diploma/GED 3 20.0 2 14.3 
 Associates degree 8 53.4 4 28.6 
 Bachelor’s degree 2 13.3 5 35.7 
 Graduate degree 2 13.3 1 7.1 
Patient Cancer Diagnosis     
 Breast 5 35.7 - - 
 Lung, Testicular 1 7.1 - - 
 Multiple myeloma 1 7.1 - - 
 Mouth, Tongue 1 7.1 - - 
 Prostate 2 14.2 - - 
 Nonhodgkins lymphoma 1 7.1   
 Ovarian 1 7.1   
 Kidney 1 7.1   
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 Patient Surrogate 
Demographic n % n % 
Surrogate Relationship     
 Spouse - - 8 53.3 
 Child - - 3 20.0 
 Friend - - 4 26.7 
How patients were referred to study     
 VIM 5 33.3 - - 
 Urologist 1 6.7 - - 
 From a Study Participant  9 60.0 - - 
Employment     
 Not Currently Employed 12 80.0   
 Currently  Employed 3 20.0   
 
Research Question 1 
RQ1: Does the intervention increase congruence in reported Treatment Preferences for 
Life-Limiting Cancer Form (pretest versus posttest) between patient and matched surrogate? 
 Congruence between patient and matched surrogate for treatment preferences for life-
limiting cancer significantly increased from pretest to posttest in situations 1, 3 and 5, (low 
survival, high burden; high survival, functional disability; and CPR, high burden, respectively).  
The remaining situations 2 and 4 (poor outcome, high burden and high survival, cognitive 
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disability, respectively) had complete agreement at the posttest so that the binomial test was 
required rather than the McNemar test.  Table 3 presents the results by situation. 
 
Table 3. Results for McNemar and Binomial Tests for Congruence at Pretest and Posttest 
Situation Pretest Agreement Posttest Agreement p 
1 – low survival, high burden 53.3 (n=8) 93.3 (n=14) .031 
2 – poor outcome, high burden 60.0 (n=9) 100.0 (n=15) .001a  
3 – high survival, functional disability 26.7 (n=4) 93.3 (n=14) .002 
4 – high survival, cognitive disability 66.7 (n=10) 100.0 (n=15)  .002 a  
5 – CPR, high burden 40.0 (n=6) 93.3 (n=14) .008 
Note.  a Binomial tests used due to 100 % agreement at posttest. 
 
Research Question 2 
RQ2: Are there significant differences in the proportion of congruence observed for 
different situations at posttest? 
The proportion of congruence observed after the intervention did not differ across the 
five situations (p ≥ 0.50). These proportion ranged from 93 % - 100%   (see Table 3)  
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Table 4. Zar’s Multiple Comparison Test of Differences in Proportions of Congruence across 
Situation at Post-test 
Situations Proportions p’ 
 1 – low survival, high burden 14/15 77.47 
2 – poor outcome, high burden 15/15 84.85 
3 – high survival, functional disability 14/15 77.47 
4 – high survival, cognitive disability 15/15 84.85 
5 – CPR, high burden 14/15 77.47 
 
Research Question 3 
Does the intervention reduce patients’ decisional conflict? 
 To examine research question 3, a paired sample t-test was conducted to assess if there 
were significant differences in decisional conflict scale (DCS) over time (pretest vs. posttest).  
The results of the dependent sample t - test were significant, t (14) =4.49, p < .001, suggesting 
that posttest decisional conflict was significantly reduced (see Table 5).  
 
 
Table 5. Results of Paired Sample t Test for DCS Scores by Time (Pretest vs. Posttest) 
 Pretest M 
(SD) 
Posttest M 
(SD) 
t df p 
DCS 25.52 
(15.57) 
16.04 
(15.41) 
4.49 14 .001 
Note: low score indicates less decisional conflict 
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Research Question 4 
Does the intervention increase patient’s anxiety? 
To examine research question 4, a paired sample t-test was conducted to assess if there 
were significant differences in patients’ anxiety over time (pretest vs. posttest). The results of the 
paired-sample t - test were not significant, t (14) = 1.75, p = .102, suggesting that there was not a 
significant difference in patients’ anxiety/stress scores over time. As can be seen from the means 
reported in Table 6, moderate levels of anxiety were reported at both time points.  
 
Table 6. Results of Paired Sample t Test for Anxiety/Stress Scores by Time (Pretest vs. Posttest) 
 Pretest M 
(SD) 
Posttest M 
(SD) 
t df p 
Anxiety/stress 2.31 
(0.33) 
2.21 
(0.33) 
1.75 14 .102 
 
Additional Analyses Assessing Intervention Fidelity and Timing 
Intervention Fidelity 
After the intervention, the Quality of Communication about EOL Form (Appendix I) was 
used to ask participants to evaluate the interview and the interviewer and rate the overall quality 
of the discussion.  As depicted in Table 7, the intervention was delivered as intended. All 
participants indicated they believed the patients’ treatment preferences would be honored 
(congruence).  All participants definitely felt the interviewer cared, listened, and gave 
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participants enough attention (Interviewer fidelity). All participants were definitely satisfied with 
the quality and effectiveness of communication (Interview fidelity). 
Timing 
All 10 patients and all seven surrogates who answered the question about timing 
answered yes, it was a good time to have a discussion about ACP. However, one patient 
specified that the best time would be one to two weeks after diagnosis because the discussion 
would mean more when she “was still going through it.” However, three patients explicitly stated 
that they liked the idea that the discussion occurred when they were not in crisis or heightened 
distress.  These patients made comments like “Good lapse between treatment and [Respecting 
Choices] Interview,” “It is easier to let your feelings be known when you aren’t in a crisis”, and 
“I have no active cancer to cause stress and affect my decision making process.” One surrogate 
appreciated having the discussion before “it is too late” and two surrogates made comments like 
“there is never a bad time” and that the discussion would be “appropriate at any time.” 
  
63 
Table 7. Frequencies and Percentages for Analyses Assessing Intervention Fidelity and Timing 
  Patient Surrogate 
  n % n % 
Question 1 – (Congruence)     
 Probably yes 3 20.0 2 13.3 
 Definitely yes 12 80.0 13 86.7 
 Question 2 – (Interviewer fidelity)     
 Probably yes - - 1 6.7 
 Definitely yes 15 100.0 14 93.3 
Question 3 – (Interviewer fidelity)     
 Definitely yes 15 100.0 15 100.0 
Question 4 – (Interviewer fidelity)     
 Probably yes - - 1 6.7 
 Definitely yes 15 100.0 14 93.3 
Question 5-  (Interview fidelity)     
 Very good 4 26.7 4 26.7 
 Excellent 11 73.3 11 73.3 
Note : questions 1-4 ratings: 1= ‘no’ 2=probably yes 3= ‘definitely yes’.  Question 5 ratings: 
1=poor 2=fair 3=good 4= very good 5= excellent 
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CHAPTER 5: DISCUSSION 
Implications 
This study investigated the impact of the Respecting Choices® DS ACP intervention on 
patients with life-limiting cancer and their surrogates. Study findings were that participating in 
the intervention significantly improved congruence between patients and surrogates regarding 
EOL treatment preferences and reduced decisional conflict without causing anxiety. More 
specifically, congruence between patients and matched surrogates for patient treatment 
preferences significantly increased from pretest to posttest in all five situations. Feedback 
obtained from the participants indicated that everyone who participated in this study found the 
Respecting Choices® DS ACP intervention to be acceptable and beneficial.  
Although it seems obvious that surrogates would have a greater understanding of 
patients’ goals after an ACP discussion, most previous studies failed to show improved patient-
surrogate dyadic congruence between patient and surrogate understanding after an ACP 
intervention (Ditto et al., 2001; Hare et al., 1992; Layde et al., 1995; Matheis-Kraft &Roberto, 
1997; Seckler et al., 1991; SUPPORT, 1995; Uhlmann et al., 1988; Wilkinson et al., 2007; 
Zweibel & Cassel, 1989). The only studies that have found ACP to be effective in increasing 
patient-surrogate dyadic congruence have included the elements that are incorporated into the 
Respecting Choices DS ACP (Briggs, 2003; Briggs et al., 2005; Detering,et al.,2010; Kirchhoff, 
et al.,2010; Lyon et al., 2009; Schwartz et al., 2002;Song et al., 2005). Thus, findings from this 
study add to the body of literature that supports the essential elements of the Respecting Choices 
intervention.  
One of these Respecting Choices DS ACP elements places importance on surrogate 
selection, specifically instructing patients to purposefully select a surrogate who is willing and 
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capable of making decisions consistent with their values and goals (Briggs et al., 2004; Singer et 
al. 1998, Schwartz et al., 2003).  Consistent with this element, the researcher instructed patients 
who expressed an interest in study participation to select a surrogate whom they believed could 
best understand and support their wishes. Selected surrogates were required for study 
participation, as the intervention was designed for surrogates to be included in the ACP 
discussion. This requirement may have contributed to the success of the intervention because 
chosen surrogates may have been more open to and interested in engaging in EOL discussions 
than other people in the patients’ interpersonal networks.  
Another Respecting Choices DS ACP element places importance on having a trained 
facilitator guide the ACP discussion between the patient and surrogate. The requirement for 
facilitator training acknowledges that discussing EOL is difficult for health professionals and lay 
persons and additional communication skills are needed to help patients communicate their 
wishes to surrogates.  One of the reasons for this study’s success may be because the facilitator 
successfully completed a certified training program and had the skills to help patients have more 
effective EOL discussions with their surrogates.  
The opportunity to discuss individual concerns is another key element in the Respecting 
Choices ACP intervention. Discussing individual concerns includes helping patients reflect on 
their goals and values and how these goals and values could direct treatment decisions. For 
example, most patients in this study said initially that they were willing to accept a trial of 
chemotherapy, regardless of their prognosis. With further discussion, the facilitator helped these 
patients understand the possible outcomes of a chemotherapy trial and adjust their expectations 
and clarify their wishes accordingly. In addition to reconsidering their general acceptance of 
chemotherapy, these patients were able to articulate possible outcomes that would make 
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acceptance of this treatment conditional. For example, patients identified loss of mental capacity 
or the inability to take care of themselves as conditions for not trying another trial of 
chemotherapy. Surrogates, by being present and engaged in the discussion, were better able to 
understand what would be unacceptable outcomes for the patient. Skilled ACP facilitation that 
included values clarification and included patient-surrogate communication about those values 
were absent from interventions that were evaluated in studies that found the interventions 
unsuccessful in improving patient-surrogate communication and congruence.  
The perception that ACP discussions will raise anxiety and decrease hope in patients with 
life limiting cancer was not supported in this study. Consistent with findings reported by 
previous studies (see for example, Hancock et al., 2007; Lyon et al., 2009; Song et al., 2005; 
Tang, Li, & Chen, 2008; Wright et al., 2008), this study found that talking about EOL is not 
associated with greater distress or anxiety. More specifically, there were no significant 
differences between the pre- and post-test measure of state anxiety.  Nonetheless, it important to 
note that anxiety was noted in patients when recruiting participants for this study. Not everyone 
who was approached for possible study participation was willing to discuss EOL. In fact, most 
participants reported that they were reluctant initially to discuss EOL issues. However, after 
participating most of participants’ comments indicated that they were highly satisfied with the 
intervention and relieved by discussing their EOL concerns. The number of participants who 
actively recruited others to participate in the study is another testimony to participant satisfaction 
and the relief they obtained by receiving the intervention. 
Study findings also mostly support earlier research that indicates the ACP process should 
occur early in the patient’s illness before crises occur (Briggs & Hammes, 2008/2010; Hiltunen 
et al., 1999; Sulmasy et al., 1998). Patients participating in this study had either completed 
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treatment or were receiving treatment because of recurrence. All participants who responded to 
the question about Timing answered that after completing initial treatment was a good time 
period to have a discussion about ACP. Only one participant commented that the best time would 
be one to two weeks after diagnosis when she was still going through initial treatment.  
The reasons for nonparticipation may also support the importance of having ACP 
discussions early in the illness. Seven eligible participants who were referred from VIM and 
initially expressed interest, were unable to participate because they were too ill from a recurrence 
of cancer. For example, one patient was admitted to an intensive care unit shortly after being 
referred to the study. Another reason for non-participation was that patients felt their loved ones 
had already assumed too much burden as a result of their cancer recurrence and asking them to 
participate in an EOL discussion would add to their burden. Perhaps these patients could have 
benefited from having this ACP discussion at a less stressful time in their illness, before another 
medical crisis occurred.  
Limitations 
There are a number of limitations that need to be considered when interpreting the study 
findings.  First, for ethical reasons to not withhold a highly promising intervention, the design 
was not a randomized control trial (RCT). A RCT would provide the strongest evidence that it 
was the intervention that increased patient-surrogate congruence. Without this design, it could be 
argued that participants, by virtue of volunteering to take part in the intervention, were more 
open to and perhaps more reflective about EOL issues. This possible explanation is particularly 
applicable to one of the criteria for study participation, namely having a surrogate who was not 
only willing to participate but also willing and capable of making decisions consistent with 
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patient values and goals. However, it could also be argued that even people who are open and 
reflective need a trained facilitator to fully understand treatment consequences and use this 
understanding for clarifying and communicating EOL treatment preferences. These skills are 
beyond most lay people, particularly when they are personally dealing with a life limiting illness. 
As previously described, the facilitator in this study was a cancer expert with training in values 
clarification and communication.   
Second, the sample was homogenous with regard to racial background (i.e., all of the 
participants were Caucasian). Racial and ethnic differences in ACP have been well documented 
and particular ethnic groups may be resistant to different aspects of planning (Smith et al, 2007). 
There is ample evidence that Caucasians are more likely to have ACP discussions than other 
racial/ethnic groups (Carr et al., 2012; Rhoades & Teno, 2010). Therefore, caution needs to be 
taken in generalizing results to racial or ethnic groups other than Caucasians.         
Third, it is possible that reports of satisfaction with the intervention were biased by the 
presence of the researcher when participants completed the Quality of Communication form. The 
researcher delivered the intervention and, in part, was being evaluated by questions about the 
quality of communication. Response burden also deserves consideration. Participants completed 
the Quality of Communication form last, after an emotionally demanding discussion. They may 
have been fatigued, which could have decreased the accuracy of their responses.   However, it is 
noteworthy that participants spontaneously offered positive comments about the intervention 
before they were asked formally. For example, most patients and surrogates expressed feeling 
relieved during the intervention when the facilitator assisted them to acknowledge and explore 
emotionally distressing concerns about EOL.  
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Fourth, the Respecting Choices DS ACP intervention was evaluated in its entirety rather 
than evaluating each of the specific elements mentioned above.   Thus, there is no way of 
knowing if the success of the intervention can be attributed to any one element or a select 
configuration of elements, such as delivery by a trained facilitator, surrogate selection, or the 
focus on values and individual concerns.  The strongest evidence for the conclusion that all of 
the elements are essential comes from omission; that is that the literature contains evidence 
interventions that were not successful in improving patient-surrogate congruence in EOL 
decision making lacks one or more of these elements.    
Finally, the Respecting Choices DS ACP intervention is adapted to be disease specific. 
This adaptation requires that facilitators have some knowledge of the disease under 
consideration. Previous studies have used nurses or allied health workers such as social workers 
and chaplains (Briggs et al., 2004; Song et al., 2005) and (Detering et al., 2010: Kirchhoff et 
al., 2010; Lyons et al., 2009). However these studies were of patients suffering from other 
diseases, such as congestive heart, respiratory, or kidney failure. Life-limiting cancer may 
require more mastery of the subject matter than these other diseases because numerous and 
often controversial cancer treatment options are widely used. Allied health workers or nurses 
without a specialization in cancer may not understand the numerous cancer treatment options. 
Because the facilitator in this study was a nurse who has experience caring for patients 
diagnosed with cancer and in EOL situations, it is not clear if study findings can be generalized 
to facilitators who do not have this clinical training.  
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Implication for Practice and Policy 
The study findings provide information for a number of policy and practice changes for 
ACP.  First, participant reports of satisfaction with the intervention and the study finding that the 
Respecting Choices® DS-ACP intervention did not increase anxiety can be used to persuade 
oncologists and other health professionals that they need not be wary of referring patients for 
EOL discussions with trained facilitators. As evidenced by the literature, oncologists and other 
health professionals have often acted as gatekeepers who are reluctant to engage or refer patients 
for ACP because of their wish to protect their patients from stressful discussions about EOL.  
Their unsubstantiated concerns have limited referrals for ACP and are contributing to billions of 
dollars in unwanted health care.   
The success of the intervention demonstrated in this study for improving patient-
surrogate communication about EOL decisions can also be used to influence health policy. Given 
the relief and satisfaction expressed by participants, study findings support making the 
intervention part of usual care at facilities and practices that provide care for patients with life 
limiting cancer. Resources should be made available to train facilitators and make the 
intervention accessible at these facilities and practices. If future research documents that 
increased patient –surrogate congruence is indeed effective for respecting patient wishes at EOL, 
then policies about training and access should be mandated.  
Delivering this intervention during different stages in the progression of a patient's illness 
or cancer progression was not compared in this study. This study did not make comparisons 
about different times in the patient’s illness or cancer progression about when to deliver the 
intervention. However, participant satisfaction with when the intervention was delivered in this 
study supports delivering the intervention well before a medical crisis.        
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Implications for Future Research 
Future research is needed to determine if increased patient-surrogate congruence does 
indeed lead to patients’ wishes being followed at EOL and reduces decisional conflict and stress 
in surrogates. The recommended study design for this future research is a prospective one that 
follows patients and surrogates post intervention through to patients’ EOL. As previously 
discussed, a Phase I clinical trial was chosen for the present study for ethical reasons to not 
withhold an intervention with promise. However, a comparative design that includes a naturally 
occurring comparison group (i.e., those who receive the standard approach) could be used in a 
future study to investigate the critical question of whether the intervention achieves these final 
outcomes (patient wishes being followed and less surrogate decisional conflict and distress) at 
EOL. For example, participants who receive the intervention could be followed prospectively to 
compare EOL care with those who did not receive the intervention. Patients and surrogates who 
did not receive the intervention could be recruited in the study at patients’ EOL for comparison, 
thereby averting the ethical issue of withholding treatment.  
Additional research is also needed with racial and ethnic groups whose reluctance to 
engage in EOL discussion has been documented in the literature. This research is needed to 
determine if the Respecting Choices DS ACP intervention is culturally appropriate or needs to 
be modified when used with certain racial or ethnic groups. A recommended approach would 
be to employ an exploratory qualitative design to understand group-specific values and 
perspectives about ACP. For example, conducting focus groups with members of specific racial 
or ethnic groups could generate informative discussions about within group similarities and 
difference in preferred ACP approaches. Approaching racial or ethnic groups through 
organizations that they trust, such as churches and matching the racial or ethnic background of 
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the focus group facilitator might increase their willingness to participate in focus groups about 
EOL values and perspectives.    
Future research is also needed to determine which types of professionals are best suited 
for the role of ACP facilitator for patients with life-limiting cancer. Since implementation of 
the Respecting Choices DS ACP intervention is illness-specific and requires advanced 
knowledge of specific illness and related treatment outcomes, it may be that facilitators need to 
be health providers with a particular medical or nursing specialty. Since there are many types of 
cancer and different cancer- and patient-specific treatments, specialization may be even more 
important for intervening with patients with life limiting cancer. Thus future research is needed 
to determine the knowledge base needed to effectively facilitate ACP with this population. A 
comparative design is recommended to answer this research question. For example, 
professionals with differing degrees of clinical specialty expertise could be compared for 
participant satisfaction and patient-surrogate congruence as well as whether these intermediary 
outcomes lead to the final outcomes respecting patients’ EOL wishes and decreasing surrogate 
decisional conflict and distress at end of life.  In addition, certified training programs for 
preparing facilitators to deliver the Respecting Choices DS ACP intervention could contribute 
to evaluating the question about the best educational preparation for becoming a certified 
facilitator.    
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APPENDIX A: STATEMENT FOR TREATMENT PREFERENCES FOR LIFE-
LIMITING CANCER 
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APPENDIX B: VERBAL ASSESSMENT QUESTIONS 
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Do you understand that information in the advance directive contains choices that will be acted 
upon in the future, not the present? 
 
Do you understand that the preferences in the advance directive will be honored only when you 
are no longer capable?  
 
Do you understand the choice to select a surrogate decision maker and/or specify medical 
preferences? 
 
Do you understand that the choices made can be changed at any time?  
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APPENDIX C: INTRODUCTORY LETTER 
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My name is Lynn Waser. I am a Registered Nurse, and a doctoral candidate at the University of 
Central Florida. I am also an Advanced Care Planning Facilitator.  I am conducting a study on 
assisting patients diagnosed with cancer to make plans for future medical treatments and 
promoting respect for their choices.  
The purpose of this study is to evaluate whether a specially designed advance care planning 
interview concerning a patient’s medical care preferences and his/her chosen surrogate’s 
preparation for future medical decision-making is beneficial. This study will address your wishes 
and preferences for medical treatment if you became unable to make such decisions in the future.  
You will need to select a surrogate, someone you might wish to make health care decisions for you, 
should you become unable to make such decisions in the future.  If your surrogate and you agree I 
will interview you and your surrogate.  The interview will provide an opportunity for you and your 
surrogate to think about your future medical treatment choices in the context of your current 
illness and promote your surrogate’s understanding of your preferences for medical treatment.  For 
this reason, your surrogate will be with you during the interview. The interview will be a 1 to 1½ 
hour discussion and will involve answering short questionnaires that should take no more than 30 
minutes. 
If you would be kind enough to write your name and phone number in the space below, I will 
contact you to answer any questions you have regarding this study. You can also call me at:  (Phone 
Number)   
Thank you  
Lynn Waser MSN RN, Doctoral Candidate and Researcher 
Your Name and Contact Phone Number or E-Mail: ___________________________________ 
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APPENDIX D: INFORMED CONSENT 
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APPENDIX E: RESPECTING CHOICES ® DS-ACP INTERVIEW STAGES  
  
88 
Respecting Choices Disease Specific Advance Care Planning Interview  
Stage 1: Assess Illness Beliefs, Goals, and Values 
 
The Respecting Choices ACP begins with the facilitator explaining the purpose of the 
discussion as an opportunity for the patients and their surrogate to understand and think about the 
life-sustaining treatment choices the patient would want if unable to make his or her own 
decisions in the future. The ACP facilitator assesses patient and surrogate understandings of the 
patient’s current medical condition, prognosis, and potential complications. The facilitator 
explores how patients’ health conditions have affected their lives, what things are most 
meaningful to them, and expectations for their current plan of care. As the interview progresses, 
this information helps patients reflect on whether the burdens of particular life sustaining 
treatment match their goals for living well (Briggs & Hammes, 2008/2010).    
Stage 2: Exploring Experiences 
The facilitator explores the patient’s experience with previous hospitalizations and with 
family and friends who have been seriously ill or died. These conversations help the facilitator 
assess what the patient learned and how those experiences may have helped or hindered the 
patient’s ability to plan for the future. The facilitator also explores the quality of previous 
advance care planning discussions with loved ones because while patients often feel they have 
had enough discussion surrogates continue to lack understanding (Briggs & Hammes, 
2008/2010).        
Stage 3: Explaining the Purpose of Advance Care Planning 
The facilitator weaves information gained from patients and surrogates during the first 
two stages of the interview to help them understand the purpose of more specific advance care 
planning. This discussion sets the stage for discussing specific medical decisions patients want 
their chosen surrogates to understand and to act upon in the future. The goal is to prepare the 
surrogates to be able to fully represent the patient’s wishes (Briggs & Hammes, 2008/2010).  
Stage 4: Clarifying Goals for Life Sustaining Treatment Preferences  
During the fourth element, the facilitator uses the statement of treatment preferences for 
life-limiting cancer document to help patients express goals for life-sustaining treatment and 
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prepare surrogates for the role for future substitute decision-maker. The scenarios describe real 
situations, specific to life-limiting cancer that the patient may experience and types of treatment 
decisions the surrogate might be asked to make.  The ACP facilitator explains the benefits and 
burdens of life-sustaining treatments and discusses the importance of choosing a healthcare 
surrogate that can represent the patients’ decisions  (Briggs & Hammes, 2008/2010).  
Stage 5: Summary 
During this element, the patient, surrogate, and ACP facilitator discuss the new 
information and the value of the discussion for the patient and surrogate.  Any outstanding issues 
are raised.  The need for future discussion as the situation and preferences change are reviewed 
(Briggs & Hammes, 2008/2010).   
Stage 6: Follow-up Plan 
A plan about ways to communicate the written plan to health care providers and other 
family members are developed. Referrals to appropriate resource, such as a social worker, will 
be provided to address any issues that may have occurred during the interview (Briggs & 
Hammes, 2008/2010).   
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APPENDIX F: SOCIODEMOGRAPHIC INSTRUMENTS 
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Socio Demographic Form for Respecting Choices DS-ACP Study (Patient 
Version)     
 
1) Age (please check one): 
□ 21-29 
□ 30-39 
□ 40-49 
□ 50-54 
□ 55-59 
□ 60-64 
□ 65-69 
□ 70-74 
□ 75-79 
□ 80 & up 
 
 
2) Gender (please check one): 
□ Male 
□ Female 
 
3) Marital Status (please check one): 
□ Single 
□ Married 
□ Separated 
□ Divorced 
□ Widowed 
□ Domestic Partnership 
 
4) Religious Affiliation you were raised in (please check one): 
□ Christian 
□ Catholic 
□ Jewish 
□ Muslim 
□ Hindu 
□ Other 
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5) Religious affiliation that you currently practice (please check one): 
□ Christian 
□ Catholic 
□ Jewish 
□ Muslim 
□ Hindu 
□ Other  
 
6) How often do you attend religious services (please check one): 
□ Once a week or more  
□ About once a month 
□ Holy Days and special occasions only 
□ Never 
□ Other (please specify):  
 
7) Housing Status (please check one): 
□ Home 
□ Assisted Living Facility 
□ Other (please specify): _________________________________________ 
 
8) Education Level (please check one): 
□ Less than High School 
□ High School Diploma/GED 
□ Some College 
□ Associates Degree 
□ Bachelors Degree 
□ Masters Degree 
□ Doctorate 
 
9) Occupation (please check one): 
□ Administrative Support 
□ Arts/Design/Entertainment 
□ Business 
□ Computer Technology 
□ Construction 
□ Education 
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□ Engineers/Architects 
□ Forestry - Agriculture 
□ Food Service 
□ Graphic Design 
□ Healthcare 
□ Homemaker or Parenting 
□ Legal 
□ Maintenance 
□ Management 
□ Military 
□ Services 
□ Repair/Installation 
□ Sales 
□ Science 
□ Social Service 
□ Transportation 
□ Other (please specify)_______________________ 
 
10) Income Level (please check one): 
□ $0-$9,999 
□ $10,000-$19,999 
□ $20,000-$34,999 
□ $35,000-$44,999 
□ $45,000-$54,999 
□ $55,000-$64,999 
□ $65,000-$74,999 
□ $75,000-$99,999 
□ $100,000 & up 
 
11) Cancer Diagnosis (please check one): 
□ Breast 
□ Colon 
□ Lung 
□ Liver 
□ Bone 
□ Multiple Myeloma 
□ Leukemia 
□ Other (please specify): ___________________________________ 
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12) Relationship to Health Care Surrogate (please check one): 
□ Spouse 
□ Parent 
□ Child 
□ Sibling 
□ Other Relative 
□ Friend 
□ Other (please specify): ___________________________________ 
 
13) Where and how did you hear about this study?  
 
14) What is your understanding of your cancer diagnosis? 
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Socio Demographic Form for Respecting Choices DS-ACP Study (Surrogate 
Version) 
 
1) Age (please check one): 
□ 21-29 
□ 30-39 
□ 40-49 
□ 50-54 
□ 55-59 
□ 60-64 
□ 65-69 
□ 70-74 
□ 75-79 
□ 80 & up 
 
2) Gender (please check one): 
□ Male 
□ Female 
 
3) Marital Status (please check one): 
□ Single 
□ Married 
□ Separated 
□ Divorced 
□ Widowed 
□ Domestic Partnership 
 
4) Religious Affiliation that you were raised in (please check one): 
□ Christian 
□ Catholic 
□ Jewish 
□ Muslim 
□ Hindu 
□ Other 
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5) Religious affiliation that you currently practice (please check one): 
□ Christian 
□ Catholic 
□ Jewish 
□ Muslim 
□ Hindu 
□ Other 
  
6) How often do you attend religious services (please check one): 
□ Once a week or more  
□ About once a month 
□ Holy Days and special occasions only 
□ Never 
□ Other (please specify):   
 
7) Education Level (please check one): 
□ Less than High School 
□ High School Diploma/GED 
□ Some College 
□ Associates Degree 
□ Bachelors Degree 
□ Masters Degree 
□ Doctorate 
 
8) Occupation (please check one): 
□ Administrative Support 
□ Arts/Design/Entertainment 
□ Business 
□ Computer Technology 
□ Construction 
□ Education 
□ Engineers/Architects 
□ Forestry - Agriculture 
□ Food Service 
□ Graphic Design 
□ Healthcare 
□ Homemaker or Parenting 
□ Legal 
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□ Maintenance 
□ Management 
□ Military 
□ Services 
□ Repair/Installation 
□ Sales 
□ Science 
□ Social Service 
□ Transportation 
□ other 
 
9) Income Level (please check one): 
□ $0-$9,999 
□ $10,000-$19,999 
□ $20,000-$34,999 
□ $35,000-$44,999 
□ $45,000-$54,999 
□ $55,000-$64,999 
□ $65,000-$74,999 
□ $75,000-$99,999 
□ $100,000 & up 
 
10) Relationship to Patient (please check one): 
□ Spouse 
□ Child 
□ Parent 
□ Sibling 
□ Other Relative 
□ Friend 
□ Other (please specify): ___________________________________ 
 
11) Where and how did you learn about this study?  
 
12)  What is your understanding of your loved ones cancer diagnosis? 
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APPENDIX G: DECISIONAL CONFLICT SCALE 
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APPENDIX H: SPIELBERGER STATE ANXIETY SCALES 
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APPENDIX I: QUALITY OF COMMUNICATION ABOUT END-OF-LIFE CARE   
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The quality of patient-interviewer communication about end-of-life care 
(Completed by Patients) 
                                                                                             ID# :  
 
The following questions are to evaluate the discussion that you just had.  Please show how you think 
about the communication with these comments by circling the number from 1 (no) to 3 (definitely yes).  
The last question is to rate overall quality of the discussion you had.  Your answers are confidential. 
 No Probably 
yes 
Definitely yes 
Regarding the kinds of treatment you would want if you got too sick to speak for 
yourself: 
1. Do you think that your treatment 
preferences are known? 
1 2 3 
When you talked about the kinds of treatment:  
2. Did you feel that the interviewer cared 
about you as a person? 
1 2 3 
3. Did you feel that the interviewer listened 
to what you said? 
1 2 3 
4. Did you feel that the interviewer gave you 
enough of her attention? 
1 2 3 
Ratings: Poor Fair Good Very 
good 
Excellent 
How would you rate the overall quality of 
the discussions you just had with the 
interviewer about the kinds of treatment you 
would want if you got too sick to speak for 
your self? 
1 2 3 4 5 
 
Adapted from Schwartz, C. E., Merriman, M., Reed, G., & Hammes, B. J. (2004). Measuring patient treatment preferences in end-of-life 
care research: Applications for advance care planning interventions and response shift research. Journal of Palliative Medicine, 7, 233-
245 
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The quality of patient-interviewer communication about end-of-life care 
(Completed by Surrogates) 
                    
                                                                      ID# :  
The following questions are to evaluate the discussion that you just had.  Please show how you think 
about the communication with these comments by circling the number from 1 (no) to 3 (definitely yes).  
The last question is to rate overall quality of the discussion you just had.  Your answers are confidential. 
 No Probably 
yes 
Definitely yes 
Regarding the kinds of treatment your loved one would want if he/she got too sick to 
speak for him/herself: 
1. Do you think that your loved one’s 
treatment preferences are known? 
1 2 3 
When you talked about your loved one’s kinds of treatment:  
2. Did you feel that the interviewer cared 
about your loved one as a person? 
1 2 3 
3. Did you feel that the interviewer listened 
to what you and your loved said? 
1 2 3 
4. Did you feel that the interviewer gave 
enough of attention? 
1 2 3 
 
Ratings: 
Poor Fair Good Very 
good 
Excellent 
How would you rate the overall quality of 
the discussions you just had with the 
interviewer about the kinds of treatment your 
loved one would want if he/she got too sick 
to speak for him/herself? 
1 2 3 4 5 
 
 
 Adapted from Schwartz, C. E., Merriman, M., Reed, G., & Hammes, B. J. (2004). Measuring patient treatment preferences in end-of-life care 
research: Applications for advance care planning interventions and response shift research. Journal of Palliative Medicine, 7, 233-245. 
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